<SEC-DOCUMENT>0001323885-23-000053.txt : 20230526
<SEC-HEADER>0001323885-23-000053.hdr.sgml : 20230526
<ACCEPTANCE-DATETIME>20230526115151
ACCESSION NUMBER:		0001323885-23-000053
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230525
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
FILED AS OF DATE:		20230526
DATE AS OF CHANGE:		20230526

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AtriCure, Inc.
		CENTRAL INDEX KEY:			0001323885
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				341940305
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51470
		FILM NUMBER:		23965359

	BUSINESS ADDRESS:	
		STREET 1:		7555 INNOVATION WAY
		CITY:			MASON
		STATE:			OH
		ZIP:			45040
		BUSINESS PHONE:		513-755-4100

	MAIL ADDRESS:	
		STREET 1:		7555 INNOVATION WAY
		CITY:			MASON
		STATE:			OH
		ZIP:			45040
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>atrc-20230525.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:c03a66db-4b53-4956-9adb-aa31c32e1f2a,g:8ec2bafd-d900-45a9-907f-a72c4a0b0840,d:ad869d1fe17a4e23bfe24c7030787a5e--><html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>atrc-20230525</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV80L2ZyYWc6ZjNjZDljMzkyMTdmNDhjODljNzNjY2I3NDQ5MDU1ZDYvdGFibGU6YmU4OGY5MGNmOGU3NGM2NWJlNDdmOTQ1M2Q4ZmFlOGYvdGFibGVyYW5nZTpiZTg4ZjkwY2Y4ZTc0YzY1YmU0N2Y5NDUzZDhmYWU4Zl8wLTEtMS0xLTk3MzY0_41b935d1-8603-4b62-940d-c010376944da">0001323885</ix:nonNumeric><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV80L2ZyYWc6ZjNjZDljMzkyMTdmNDhjODljNzNjY2I3NDQ5MDU1ZDYvdGFibGU6YmU4OGY5MGNmOGU3NGM2NWJlNDdmOTQ1M2Q4ZmFlOGYvdGFibGVyYW5nZTpiZTg4ZjkwY2Y4ZTc0YzY1YmU0N2Y5NDUzZDhmYWU4Zl8xLTEtMS0xLTk3MzY0_5e4b4a72-df4a-4c20-ac82-1a83d5b59057">False</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="atrc-20230525.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001323885</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-25</xbrli:startDate><xbrli:endDate>2023-05-25</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iad869d1fe17a4e23bfe24c7030787a5e_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzM5_72e6a226-9033-441f-bc10-f944d40cdfc7">8-K</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) of the</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQx_5c9effac-c8fe-4bab-bd79-0e85d7277ac6">May 25, 2023</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ2_77090069-9121-46d6-86d7-ab7e74da266d">AtriCure, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6Y2FmM2M2ZmUxNmM1NGRkYzgxNGY4NGZjZjQxNGIwZTQvdGFibGVyYW5nZTpjYWYzYzZmZTE2YzU0ZGRjODE0Zjg0ZmNmNDE0YjBlNF8wLTAtMS0xLTk3MzY0_ebdba026-c721-4f81-9549-98c3386df86b">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6Y2FmM2M2ZmUxNmM1NGRkYzgxNGY4NGZjZjQxNGIwZTQvdGFibGVyYW5nZTpjYWYzYzZmZTE2YzU0ZGRjODE0Zjg0ZmNmNDE0YjBlNF8wLTEtMS0xLTk3MzY0_19dce32e-f8f2-45c4-b413-c83e16a942d8">000-51470</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6Y2FmM2M2ZmUxNmM1NGRkYzgxNGY4NGZjZjQxNGIwZTQvdGFibGVyYW5nZTpjYWYzYzZmZTE2YzU0ZGRjODE0Zjg0ZmNmNDE0YjBlNF8wLTItMS0xLTk3MzY0_e394d5ee-18d5-4712-be26-b7af6f14be8b">34-1940305</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:108%">(IRS Employer Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ3_db273bb9-0148-4654-9211-a07c5870bb52">7555 Innovation Way</ix:nonNumeric>, <ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQy_011b9767-882b-4306-be15-122e2df2fea5">Mason</ix:nonNumeric> <ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ4_f8b905f4-9d04-4e6d-bc46-27ff51e81d7f">OH</ix:nonNumeric> <ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQz_ed31c27d-67ed-46c3-8208-3e5a70b71046">45040</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, and Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ0_d7eed439-4ea5-4573-bbe4-23423573b505">513</ix:nonNumeric>) <ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ1_8cfddc88-aacb-4430-ba14-8e54a6dbe2ea">755-4100</ix:nonNumeric></span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:4.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6ODA0YzQ1YTMxYTY1NDVjMWExMjM0MzkzMDE2MzMwNDMvdGFibGVyYW5nZTo4MDRjNDVhMzFhNjU0NWMxYTEyMzQzOTMwMTYzMzA0M18wLTAtMS0xLTk3MzY0_c5c62b68-35da-47d1-94b4-fe4ee8d75065">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6ODA0YzQ1YTMxYTY1NDVjMWExMjM0MzkzMDE2MzMwNDMvdGFibGVyYW5nZTo4MDRjNDVhMzFhNjU0NWMxYTEyMzQzOTMwMTYzMzA0M18xLTAtMS0xLTk3MzY0_d65efd47-2750-4fa2-899e-bdf2cba7bdd4">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6ODA0YzQ1YTMxYTY1NDVjMWExMjM0MzkzMDE2MzMwNDMvdGFibGVyYW5nZTo4MDRjNDVhMzFhNjU0NWMxYTEyMzQzOTMwMTYzMzA0M18yLTAtMS0xLTk3MzY0_a48ee985-2dfc-49e7-9aed-2bb35ce35199">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6ODA0YzQ1YTMxYTY1NDVjMWExMjM0MzkzMDE2MzMwNDMvdGFibGVyYW5nZTo4MDRjNDVhMzFhNjU0NWMxYTEyMzQzOTMwMTYzMzA0M18zLTAtMS0xLTk3MzY0_7945027c-7aae-48b8-8fc2-35cee810d256">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6NmE0YzlkOGMwYzhkNGRlYmI3ZWFlYjAzZWNlMGM2ZWMvdGFibGVyYW5nZTo2YTRjOWQ4YzBjOGQ0ZGViYjdlYWViMDNlY2UwYzZlY18xLTAtMS0xLTk3MzY0_24476094-cedb-4ae3-bd57-1c28df087e69">Common Stock, $.001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6NmE0YzlkOGMwYzhkNGRlYmI3ZWFlYjAzZWNlMGM2ZWMvdGFibGVyYW5nZTo2YTRjOWQ4YzBjOGQ0ZGViYjdlYWViMDNlY2UwYzZlY18xLTEtMS0xLTk3MzY0_75a38c50-062c-4808-b025-f06cf2634408">ATRC</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6NmE0YzlkOGMwYzhkNGRlYmI3ZWFlYjAzZWNlMGM2ZWMvdGFibGVyYW5nZTo2YTRjOWQ4YzBjOGQ0ZGViYjdlYWViMDNlY2UwYzZlY18xLTItMS0xLTk3MzY0_27e21111-a9dd-4430-85cf-4fa741ec0fba">NASDAQ Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ5_9ec2abe5-1300-4e31-bd78-92f4eded31de">o</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="background-color:#ffffff;color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iad869d1fe17a4e23bfe24c7030787a5e_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02.&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the AtriCure, Inc. (the &#8220;Company&#8221;) Annual Meeting of Stockholders which was held on May 25, 2023, the stockholders of the Company approved the AtriCure, Inc. 2023 Stock Incentive Plan (the &#8220;2023 Plan&#8221;).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the 2023 Plan is to provide a means through which the Company and its affiliates may attract and retain key personnel and to provide a means whereby directors, officers, employees, consultants and advisors of the Company and its affiliates can acquire and maintain an equity interest in the Company, or be paid incentive compensation, including incentive compensation measured by reference to the value of the Company&#8217;s common stock, thereby strengthening their commitment to the welfare of the Company and its affiliates and aligning their interests with those of the Company&#8217;s stockholders. The 2023 Plan is an &#8220;omnibus&#8221; stock plan that provides for a variety of equity award vehicles to maintain flexibility. The 2023 Plan permits the grant of stock options, stock appreciation rights, restricted share awards, restricted share units and unrestricted share awards. The 2023 Plan does not permit the re-pricing of options or stock appreciation rights without the approval of stockholders and does not contain an &#8220;evergreen&#8221; provision to automatically increase the number of shares issuable under the 2023 Plan, except for certain adjustments resulting from stock splits and other specified events. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing summary of the 2023 Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the 2023 Plan filed as Exhibit 10.1 to this report. </span></div><div id="iad869d1fe17a4e23bfe24c7030787a5e_10"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07.&#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stockholders of the Company voted on five items at the Annual Meeting of Stockholders held on May 25, 2023:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The election of eight directors to serve one-year terms expiring at the 2024 Annual Meeting of Stockholders and until their successors have been duly elected and qualified;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">A proposal to ratify the appointment of Deloitte &amp; Touche LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2023;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The approval of the AtriCure, Inc. 2023 Stock Incentive Plan;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The approval of an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000; and</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">An advisory vote on the compensation of the Company&#8217;s named executive officers as disclosed in the proxy statement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nominees for director were elected based upon the following votes:</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Director Nominees</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael H. Carrel</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,688,285</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663,543</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,444</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regina E. Groves</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,606,401</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,483</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,388</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B. Kristine Johnson</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,317,157</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,030,721</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,394</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Karen N. Prange</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,342,028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005,856</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,388</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deborah H. Telman</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,676,842</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674,148</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,282</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sven A. Wehrwein</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,103,506</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,247,490</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,276</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert S. White</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,089,897</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,259,677</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,698</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maggie Yuen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,605,378</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740,663</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,231</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposal to ratify the appointment of Deloitte &amp; Touche LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2023 received the following votes:</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.766%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,108,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The approval of the AtriCure, Inc. 2023 Stock Incentive Plan received the following votes:</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.766%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,096,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The approval of an amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance thereunder by 750,000 received the following votes:</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.766%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,320,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory vote on the compensation of the Company&#8217;s named executive officers as disclosed in the proxy statement received the following votes:</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.766%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,710,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,620,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="iad869d1fe17a4e23bfe24c7030787a5e_13"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.469%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023stockincentiveplan.htm">AtriCure, Inc. 2023 Stock Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2018employeestockpurchase.htm">AtriCure, Inc. 201</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2018employeestockpurchase.htm">8 Employe</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2018employeestockpurchase.htm">e Stock Purchase Plan (Amended and Restated as of May 25, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iad869d1fe17a4e23bfe24c7030787a5e_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ATRICURE,&#160;INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 26, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Angela L. Wirick</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Angela L. Wirick</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a2023stockincentiveplan.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie888e8063ab34447a65116925d2d71fd_33"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ATRICURE, INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 STOCK INCENTIVE PLAN </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Purpose.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the AtriCure, Inc. 2023 Stock Incentive Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, employees, consultants and advisors (and prospective directors, officers, employees, consultants and advisors) of the Company and its Affiliates can acquire and maintain an equity interest in the Company, or be paid incentive compensation, including incentive compensation measured by reference to the value of Common Stock, thereby strengthening their commitment to the welfare of the Company and its Affiliates and aligning their interests with those of the Company&#8217;s stockholders. This Plan document is an omnibus document which authorizes, in addition to the Plan, the establishment of separate sub-plans (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sub Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that the Committee (defined below) may create and administer from time to time. The Plan shall be a separate and independent plan from the Sub Plans, but the total number of shares of Common Stock authorized to be issued under the Plan applies in the aggregate to both the Plan and the Sub Plans. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Definitions.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following definitions shall be applicable throughout the Plan.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) any person or entity that directly or indirectly controls, is controlled by or is under common control with the Company and&#47;or (ii) to the extent provided by the Committee, any person or entity in which the Company has a significant interest. The term &#8220;control&#8221; (including, with correlative meaning, the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;), as applied to any person or entity, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person or entity, whether through the ownership of voting or other securities, by contract or otherwise.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, individually or collectively, any Incentive Stock Option, Nonqualified Stock Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Other Stock-Based Award and Performance Compensation Award granted under the Plan. For purposes of Section 5(c) of the Plan, &#8220;Award&#8221; and &#8220;Award under the Plan&#8221; shall also mean any stock-based award granted under the Prior Plan and outstanding on the Effective Date. </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement, either in written or electronic format, between the Company and a Participant setting forth the terms and conditions of an Award granted to the Participant. </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company. </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means  with respect to any Participant, unless otherwise provided in the applicable Award Agreement (i) indictment for, conviction of, or plea of guilty or no contest by the Participant to a felony, or of any criminal act, that has an adverse effect on the Participant&#8217;s qualifications or ability to perform his duties&#59; (ii) the unreasonable deliberate and material failure or refusal by the Participant to perform his employment duties (other than as a result of PTO, sickness, disability, illness or injury), and the failure to rectify the same within thirty (30) days after the Company shall have given notice to the Participant identifying such failure or refusal and demanding that it be rectified&#59; (iii) the Participant&#8217;s commission of any act of fraud, embezzlement, dishonesty or other misconduct that has caused, or would reasonably be expected to cause, material injury or economic harm to the Company&#59; (iv) an act of gross negligence on the part of the Participant that has caused, or would reasonably be expected to cause, material injury or economic harm to the Company&#59; (v) a deliberate and material violation of a written material Company policy&#59; or (vi) a material breach of the Plan or any change-in control or non-disclosure agreement to which Participant and the Company may be parties (or, in each case, any successor thereto or amendment thereof) which (and only if the same shall be curable) Participant fails to cure within thirty (30) days after the Company shall have given notice to the Participant identifying such breach and demanding that it be cured. Any purported termination by the Company for Cause which does not satisfy the applicable requirements of this Section 2(d) shall be conclusively deemed to be a termination by the Company without Cause for purposes of the Plan. </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58; </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">Any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">The consummation of the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">A change in the composition of the Board occurring within a two-year period, as a result of which fewer than a majority of the directors are Incumbent Directors. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incumbent Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means directors who either (A) are directors as of the effective date of the Plan, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company)&#59; or </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding anything herein to the contrary, and only to the extent that an Award is subject to Code Section 409A and payment of the Award pursuant to the application of the definition of &#8220;Change in Control&#8221; above would cause such Award not to otherwise comply with Code Section 409A, payment of an Award may occur upon a Change in Control only to the extent that the event constitutes a &#8220;change in the ownership or effective control&#8221; of the Company or a &#8220;change in the ownership of a substantial portion of the assets&#8221; of the Company under Code Section 409A.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended, and any successor thereto. Reference in the Plan to any section of the Code shall be deemed to include any regulations or other interpretative guidance under such section, and any amendments or successor provisions to such section, regulations or guidance. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a committee of at least two people as the Board may appoint to administer the Plan or, if no such committee has been appointed by the Board, the Board. The Committee shall be comprised of the members of the Board&#8217;s Compensation Committee unless and until otherwise determined by the Board. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the common stock, $0.001 par value per share, of the Company (and any stock or other securities into which such common stock may be converted or into which it may be exchanged). </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means AtriCure, Inc., a Delaware corporation, and any successor thereto. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Date of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date on which the granting of an Award is authorized, or such other date as may be specified in such authorization. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">total and permanent disability as defined in Section 22(e)(3) of the Code, provided that in the case of Awards other than ISOs, the Committee in its discretion may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Committee from time to time, including using the definition of disability in the long term disability plan of the Company or an Affiliate. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date on which the Plan is initially approved by the stockholders of the Company. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date Share Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given such term in Section 5(b). </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who is (i) a &#8220;non-employee director&#8221; within the meaning of Rule 16b-3 under the Exchange Act and (ii) an &#8220;independent director&#8221; under the rules of NASDAQ or any other securities exchange or inter-dealer quotation system on which the Common Stock is listed or quoted, or a person meeting any similar requirement under any successor rule or regulation. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any (i) individual employed by the Company or an Affiliate&#59; (ii) director or officer of the Company or an Affiliate&#59; (iii) consultant or advisor to the Company or an Affiliate who may be offered securities registrable pursuant to a registration statement on Form  S-8 under the Securities Act&#59; or (iv)  individual who has accepted an offer of employment or service as an employee, director, officer, consultant or advisor with the Company or its Affiliates (and would satisfy the provisions of any of clauses (i) through (iii) above once he or she begins employment with or providing services to the Company or its Affiliates), who, in the case of each of clauses (i) through (iv) above, has entered into an Award Agreement or who has received written notification from the Committee or its designee that he or she has been selected to participate in the Plan. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended, and any successor thereto. Reference in the Plan to any section of (or rule promulgated under) the Exchange Act shall be deemed to include any rules, regulations or other interpretative guidance under such section or rule, and any amendments or successor provisions to such section, rules, regulations or guidance. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given such term in Section 7(b) of the Plan. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.61pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) unless otherwise determined by the Committee, on a given date, (A)  if the Common Stock is listed on a national securities exchange, the closing sales price of the Common Stock reported on the primary exchange on which the Common Stock is listed and traded on such date, or, if there is no such sale on that date, then on the last preceding date on which such a sale was reported, or (B) if the Common Stock is not listed on any national securities exchange but is quoted in an inter-dealer quotation system on a last sale basis, the average between the closing bid price and ask price reported on such date, or, if there is no such sale on that date, then on the last preceding date on which a sale was reported&#59; or (ii) if the Common Stock is not listed on a national securities exchange or quoted in an inter-dealer quotation system on a last sale basis, the amount determined by the Committee in good faith to be the fair market value of the Common Stock. In the case of an Incentive Stock Option, Fair Market Value shall be determined by the Committee in accordance with Code Section 422.  For Awards intended to be exempt from Code Section 409A, Fair Market Value shall be determined by the Committee in accordance with Code Section 409A. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Full-Value Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Restricted Stock, Restricted Stock Units, or unrestricted Common Stock.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">u.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Immediate Family Members</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 14(c).</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ISO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Option that is designated by the Committee as an incentive stock option as described in Section 422 of the Code and otherwise meets the requirements set forth in the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">w.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.28pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnifiable Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 4(e) of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NASDAQ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean The NASDAQ Global Select Market.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Negative Discretion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the discretion authorized by the Plan to be applied by the Committee to eliminate or reduce the size of a Performance Compensation Award.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">z.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Nonqualified Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Option that is not designated by the Committee as an Incentive Stock Option.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aa.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.64pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Employee Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Board who is not an employee of the Company or any Affiliate.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ab.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted under Section 7 of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ac.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.64pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given such term in Section 7(c) of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ad.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Stock-Based Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted under Section 10 of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ae.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.64pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Eligible Person who has been selected by the Committee to participate in the Plan and to receive an Award.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">af.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.74pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to an Eligible Person, any applicable Award Agreement or any other employment, consulting, or other service or compensatory or severance agreement between the Eligible Person and the Company or an Affiliate, or any compensatory or severance plan, program, or arrangement of the Company or an Affiliate in which the Eligible Person participates.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ag.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Compensation Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean any Award, whether cash-based or stock-based, designated by the Committee as a Performance Compensation Award pursuant to Section 11 of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ah.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Criteria</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the criterion or criteria that the Committee shall select for purposes of establishing the Performance Goal(s) for a Performance Period with respect to any Performance Compensation Award under the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ai.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.3pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Formula</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean, for a Performance Period, the one or more objective formulae applied against the relevant Performance Goal to determine, with regard to the Performance Compensation Award of a particular Participant, whether all, some portion but less than all, or none of the Performance Compensation Award has been earned for the Performance Period.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aj.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.3pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean, for a Performance Period, the one or more goals established by the Committee for the Performance Period.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ak.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the one or more periods of time, as the Committee may select, over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to, and the payment of, a Performance Compensation Award.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">al.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.3pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Permitted Transferee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 14(c) of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">am.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.3pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning given such term in the definition of &#8220;Change in Control.&#8221;  </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this AtriCure, Inc. 2023 Stock Incentive Plan, as amended from time to time.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ao.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prior Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the AtriCure, Inc. 2014 Stock Incentive Plan, as such plan may have been amended and&#47;or restated.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ap.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period of time determined by the Committee during which an Award is subject to restrictions or, as applicable, the period of time within which performance is measured for purposes of determining whether an Award has been earned.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Common Stock, subject to certain specified restrictions (including, without limitation, a requirement that the Participant remain continuously employed or provide continuous services for a specified period of time), granted under Section 9 of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ar.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.74pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an unfunded and unsecured promise to deliver shares of Common Stock, cash, other securities or other property, subject to certain restrictions (including, without limitation, a requirement that the Participant remain continuously employed or provide continuous services for a specified period of time), granted under Section 9 of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.18pt">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means retirement with the Company at or after age 65.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.3pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SAR Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given such term in Section 8(c) of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">au.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Act of 1933, as amended, and any successor thereto. Reference in the Plan to any section of (or rule promulgated under) the Securities Act shall be deemed to include any rules, regulations or other interpretative guidance under such section or rule, and any amendments or successor provisions to such section, rules, regulations or guidance.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">av.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Separation From Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in Section 409A(a)(2)(A)(i) of the Code.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aw.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.85pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Specified Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Participant who meets the definition of &#8220;specified employee,&#8221; as defined in Section 409A(a)(2)(B)(i) of the Code.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ax.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted under Section 8 of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ay.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strike Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given such term in Section 8(b) of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">az.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.64pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to any specified Person&#58;</font></div><div style="margin-top:6pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)         any corporation, association or other business entity of which more than 50% of the total voting power of shares of company voting securities (without regard to the occurrence of any contingency and after giving effect to any voting agreement or stockholders&#8217; agreement that effectively transfers voting power) is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person (or a combination thereof)&#59; and</font></div><div style="margin-top:6pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)         any partnership (or any comparable foreign entity) (a) the sole general partner (or functional equivalent thereof) or the managing general partner of which is such Person or Subsidiary of such Person or (b) the only general partners (or functional equivalents thereof) of which are that Person or one or more Subsidiaries of that Person (or any combination thereof).</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ba.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Substitute Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given such term in Section 5(e).</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bb.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sub Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning given such term in Section 1.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Effective Date&#59; Duration.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan is effective as of the Effective Date. The expiration date of the Plan, on and after which date no Awards may be granted hereunder, shall be the tenth anniversary of the Effective Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that such expiration shall not affect Awards then outstanding, and the terms and conditions of the Plan shall continue to apply to such Awards.</font></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Administration.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The Committee shall administer the Plan. To the extent required to comply with the provisions of Rule 16b-3 promulgated under the Exchange Act (if the Board is not acting as the Committee under the Plan), it is intended that each member of the Committee shall, at the time he or she takes any action with respect to an Award under the Plan, be an Eligible Director. However, the fact that a Committee member shall fail to qualify as an Eligible Director shall not invalidate any Award granted by the Committee that is otherwise validly granted under the Plan.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Subject to the provisions of the Plan and applicable law, the Committee shall have the sole and plenary authority, in addition to other express powers and authorizations conferred on the Committee by the Plan, to&#58; (i) designate Participants&#59; (ii) determine the type or types of Awards to be granted to a Participant&#59; (iii) determine the number of shares of Common Stock to be covered by, or with respect to which payments, rights, or other matters are to be calculated in connection with, Awards&#59; (iv) determine the terms and conditions of any Award, including the vesting provisions&#59; (v) determine whether, to what extent, and under what circumstances Awards may be settled or exercised in cash, shares of Common Stock, other securities, other Awards or other property, or canceled, forfeited, or suspended and the method or methods by which Awards may be settled, exercised, canceled, forfeited, or suspended&#59; (vi) determine whether, to what extent, and under what circumstances the delivery of cash, Common Stock, other securities, other Awards or other property and other amounts payable with respect to an Award shall be deferred either automatically or at the election of the Participant or of the Committee&#59; (vii) establish any Sub Plans that may be governed by the Plan&#59; (viii) interpret, administer, reconcile any inconsistency in, correct any defect in and&#47;or supply any omission in the Plan and any instrument or agreement relating to, or Award granted under, the Plan&#59; (ix) establish, amend, suspend, or waive any rules and regulations and appoint such agents as the Committee shall deem appropriate for the proper administration of the Plan&#59; (x) accelerate the vesting or exercisability of, payment for or lapse of restrictions on, Awards (including previously deferred Awards), and accelerate and determine payouts, if any, in respect of Awards with incomplete Performance Periods, in each case upon a Change in Control, death, Disability or Retirement (or on any other termination of employment) of a Participant&#59; and (xi) make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Except to the extent prohibited by applicable law or the applicable rules and regulations of any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or traded, the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and powers to any person or persons selected by it. Any such allocation or delegation may be revoked by the Committee at any time. Without limiting the generality of the foregoing, the Committee may delegate to one or more officers of the Company the authority to act on behalf of the Committee with respect to any matter, right, obligation, or election that is the responsibility of or that is allocated to the Committee herein, and that may be so delegated as a matter of law, except for grants of Awards to persons subject to Section 16 of the Exchange Act. When the Committee delegates its authority hereunder to one or more officers of the Company, it shall specify the total number of Awards that the officer or officers may award and the terms on which any Awards may be offered or sold. In no event shall the Committee authorize any officer to designate such officer as a recipient of any Awards.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations, and other decisions under or with respect to the Plan or any Award or any documents evidencing Awards granted pursuant to the Plan shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive and binding upon all persons or entities, including, without limitation, the Company, any Affiliate, any Participant, any holder or beneficiary of any Award, and any stockholder of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">No member of the Board, the Committee or any employee or agent of the Company (each such person, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnifiable Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall be liable for any action taken or omitted to be taken or any determination made with respect to the Plan or any Award hereunder (unless constituting bad faith, fraud or a willful criminal act or omission). Each Indemnifiable Person shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense (including attorneys&#8217; fees) that may be imposed upon or incurred by such Indemnifiable Person in connection with or resulting from any action, suit or proceeding to which such Indemnifiable Person may be a party or in which such Indemnifiable Person may be involved by reason of any action taken or omitted to be taken or determination made under the Plan or any Award Agreement and against and from any and all amounts paid by such Indemnifiable Person with the Company&#8217;s approval, in settlement </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">thereof, or paid by such Indemnifiable Person in satisfaction of any judgment in any such action, suit or proceeding against such Indemnifiable Person, provided that the Company shall have the right, at its own expense, to assume and defend any such action, suit or proceeding and once the Company gives notice of its intent to assume the defense, the Company shall have sole control over such defense with counsel of the Company&#8217;s choice. The foregoing right of indemnification shall not be available to an Indemnifiable Person to the extent that a final judgment or other final adjudication (in either case not subject to further appeal) binding upon such Indemnifiable Person determines that the acts or omissions or determinations of such Indemnifiable Person giving rise to the indemnification claim resulted from such Indemnifiable Person&#8217;s bad faith, fraud or willful criminal act or omission or that such right of indemnification is otherwise prohibited by law or by the Company&#8217;s Amended Articles of Incorporation or Amended and Restated Code of Regulations. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such Indemnifiable Persons may be entitled under the Company&#8217;s Amended Articles of Incorporation or Amended and Restated Code of Regulations, as a matter of law, or otherwise, or any other power that the Company may have to indemnify such Indemnifiable Persons or hold them harmless.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt">Notwithstanding anything to the contrary contained in the Plan, the Board may, in its sole discretion, at any time and from time to time, grant Awards and administer the Plan with respect to such Awards. In any such case, the Board shall have all the authority granted to the Committee under the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Grant of Awards&#59; Shares Subject to the Plan&#59; Limitations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The Committee may, from time to time, grant Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Other Stock-Based Awards and&#47;or Performance Compensation Awards to one or more Eligible Persons.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Awards granted under the Plan shall be subject to the following limitations&#58; (i) subject to Sections 5(c) and 12 of the Plan, no more than the sum of (A) 1,000,000 shares of Common Stock plus (B) the number of shares of Common Stock that, as of the Effective Date, are remaining available for issuance or delivery, and not subject to outstanding awards, under the Prior Plan may be delivered in the aggregate pursuant to Awards granted under the Plan (such sum of (A) and (B), the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date Share Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; (ii) subject to Section 12 of the Plan, no more than the number of shares of Common Stock equal to the Effective Date Share Limit may be delivered in the aggregate pursuant to the exercise of Incentive Stock Options granted under the Plan&#59; and (iii) the maximum number of shares subject to Awards granted to any Non-Employee Director during a single fiscal year shall be limited so that the Awards, taken together with any cash fees paid to such Non-Employee Director in respect of his or her service during such year (including service as a member or chair of any committees of the Board), do not exceed $1,000,000 in total value (calculating the value of any such Awards based on the grant date fair value of such Awards for financial reporting purposes). Notwithstanding the foregoing, the Board may make exceptions to the limit in the foregoing clause (iii) for (A) a non-executive chairman of the Board, provided that such non-executive chairman does not participate in the decision to award such compensation, and (B) special projects and ad hoc committee appointments, as deemed appropriate by the Board, from time to time.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The following rules shall apply in determining the number of shares of Common Stock available for grant under the Plan&#58; </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Shares of Common Stock subject to any Award shall be counted against the Effective Date Share Limit as one share of Common Stock for every share of Common Stock subject to such Award. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">To the extent that any Award is forfeited, cancelled, settled in cash, returned to the Company for failure to satisfy vesting requirements or other conditions of the Award or otherwise terminates without an issuance of shares of Common Stock being made, the Effective Date Share Limit shall be credited with one share of Common Stock for each share of Common Stock subject to such Award, and such number of credited shares of Common Stock may again be made subject to Awards under the Plan. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Any shares of Common Stock tendered by a Participant or withheld as full or partial payment of withholding or other taxes or as payment for the exercise or conversion price of an Award or repurchased by the Company with Option proceeds shall not be added back to the number of shares of Common Stock available for issuance under the Plan.  Upon exercise of a SAR, the number of shares of Common Stock subject to the Award that are being exercised shall be counted against the Effective Date Share Limit on the basis of one share of Common Stock for every share of Common Stock subject to such Award, regardless of the actual number of shares of Common Stock used to settle the SAR upon exercise. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Any shares of Common Stock underlying Awards granted through the assumption of, or in substitution for, outstanding awards previously granted to individuals who become employees of the Company as a </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">result of a merger, consolidation, acquisition or other corporate transaction shall not, unless required by law or regulation, count against the reserve of available shares of Common Stock under the Plan.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Shares of Common Stock delivered by the Company in settlement of Awards may be authorized and unissued shares, shares held in the treasury of the Company, shares purchased on the open market or by private purchase, or a combination of the foregoing.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding awards previously granted by an entity acquired directly or indirectly by the Company or with which the Company combines (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Substitute Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Shares of Common Stock underlying Substitute Awards shall not be counted against the number of shares of Common Stock available for issuance pursuant to Section 5(b) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that Substitute Awards issued in connection with the assumption of, or in substitution for, outstanding options intended to qualify as &#8220;incentive stock options&#8221; within the meaning of Section 422 of the Code shall be counted against the aggregate number of shares of Common Stock available for Awards of Incentive Stock Options under the Plan.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt">Following the Effective Date, no new awards shall be granted under the Prior Plan. For purposes of the preceding sentence, awards under the Prior Plan with performance periods that commenced prior to the Effective Date and end after the Effective Date shall not be deemed new awards granted following the Effective Date.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Eligibility.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participation shall be limited to Eligible Persons.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Options.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Option granted under the Plan shall be evidenced by an Award Agreement. Each Option so granted shall be subject to the conditions set forth in this Section 7, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. All Options granted under the Plan shall be Nonqualified Stock Options unless the applicable Award Agreement expressly states that the Option is intended to be an Incentive Stock Option. Incentive Stock Options shall be granted only to Eligible Persons who are employees of the Company and its Affiliates, and no Incentive Stock Option shall be granted to any Eligible Person who is ineligible to receive an Incentive Stock Option under the Code. No Option shall be treated as an Incentive Stock Option unless the Plan has been approved by the stockholders of the Company in a manner intended to comply with the stockholder approval requirements of Section 422(b)(1) of the Code, provided that any Option intended to be an Incentive Stock Option shall not fail to be effective solely on account of a failure to obtain such approval, but rather such Option shall be treated as a Nonqualified Stock Option unless and until such approval is obtained. In the case of an Incentive Stock Option, the terms and conditions of such grant shall be subject to and comply with such rules as may be prescribed by Section 422 of the Code. If for any reason an Option intended to be an Incentive Stock Option (or any portion thereof) shall not qualify as an Incentive Stock Option, then, to the extent of such nonqualification, such Option or portion thereof shall be regarded as a Nonqualified Stock Option appropriately granted under the Plan.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided by the Committee in the case of Substitute Awards, the exercise price (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) per share of Common Stock for each Option shall not be less than 100% of the Fair Market Value of such share (determined as of the Date of Grant)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that in the case of an Incentive Stock Option granted to an employee who, at the time of the grant of such Option, owns stock representing more than 10% of the voting power of all classes of stock of the Company or any Affiliate, the Exercise Price per share shall be no less than 110% of the Fair Market Value per share on the Date of Grant.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Vesting and Expiration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Options shall vest and become exercisable in such manner and on such date or dates determined by the Committee and shall expire after such period, not to exceed ten years, as may be determined by the Committee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Option Period shall not exceed five years from the Date of Grant in the case of an Incentive Stock Option granted to a Participant who on the Date of Grant owns stock representing more than 10% of the voting power of all classes of stock of the Company or any Affiliate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that notwithstanding any vesting dates set by the Committee, and consistent with the Committee&#8217;s power under Section 4(b), the Committee may, in its sole discretion, accelerate the exercisability of any Option upon a Change in Control, death, Disability or Retirement (or on any other termination of employment) of a Participant, which acceleration shall not affect the terms and conditions of such Option other than with respect to exercisability.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Method of Exercise and Form of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No shares of Common Stock shall be delivered pursuant to any exercise of an Option until payment in full of the Exercise Price therefor is received by the Company and the </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant has paid to the Company an amount equal to any federal, state, local and non-U.S. income and employment taxes required to be withheld. Options that have become exercisable may be exercised by delivery of written or electronic notice of exercise to the Company in accordance with the terms of the Option accompanied by payment of the Exercise Price. The Exercise Price shall be payable (i)  in cash, check, cash equivalent or shares of Common Stock valued at the Fair Market Value at the time the Option is exercised (including, pursuant to procedures approved by the Committee, by means of attestation of ownership of a sufficient number of shares of Common Stock in lieu of actual delivery of such shares to the Company), provided that such shares of Common Stock are not subject to any pledge or other security interest&#59; (ii) a &#8220;net exercise&#8221; procedure effected by withholding the minimum number of shares of Common Stock otherwise deliverable in respect of an Option that are needed to pay the Exercise Price and all applicable required withholding taxes&#59; or (iii) by such other method as the Committee may permit in its sole discretion, including without limitation&#58; (A) in other property having a fair market value on the date of exercise equal to the Exercise Price or (B) if there is a public market for the shares of Common Stock at such time, by means of a broker-assisted &#8220;cashless exercise&#8221; pursuant to which the Company is delivered a copy of irrevocable instructions to a stockbroker to sell the shares of Common Stock otherwise deliverable upon the exercise of the Option and to deliver promptly to the Company an amount equal to the Exercise Price. Notwithstanding the foregoing, if on the last day of the Option Period, the Fair Market Value exceeds the Exercise Price, the Participant has not exercised the Option, and the Option has not expired, such Option shall be deemed to have been exercised by the Participant on such last day by means of a net exercise and the Company shall deliver to the Participant the number of shares of Common Stock for which the Option was deemed exercised less such number of shares of Common Stock required to be withheld to cover the payment of the Exercise Price and all applicable required withholding taxes. Any fractional share of Common Stock shall be settled in cash.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Notification upon Disqualifying Disposition of an Incentive Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Participant awarded an Incentive Stock Option under the Plan shall notify the Company in writing immediately after the date on which he or she makes a disqualifying disposition of any Common Stock acquired pursuant to the exercise of such Incentive Stock Option. A disqualifying disposition is any disposition (including, without limitation, any sale) of such Common Stock before the later of (i) two years after the Date of Grant of the Incentive Stock Option and (ii) one year after the date of exercise of the Incentive Stock Option. The Company may, if determined by the Committee and in accordance with procedures established by the Committee, retain possession, as agent for the applicable Participant, of any Common Stock acquired pursuant to the exercise of an Incentive Stock Option until the end of the period described in the preceding sentence, subject to complying with any instructions from such Participant as to the sale of such Common Stock.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Compliance with Laws, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, in no event shall a Participant be permitted to exercise an Option in a manner that the Committee determines would violate the Sarbanes-Oxley Act of 2002, or any other applicable law or the applicable rules and regulations of the Securities and Exchange Commission or the applicable rules and regulations of any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or traded.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">No Repricing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the adjustment provisions of Section 12, without the approval of the Company&#8217;s stockholders, (A) the Exercise Price for any outstanding Option may not be decreased after the Date of Grant, (B) no outstanding Option may be surrendered to the Company as consideration for the grant of a new Option with a lower Exercise Price, and (C) no other modifications to any outstanding Option may be made that would be treated as a &#8220;repricing&#8221; under the then applicable rules, regulations or listing requirements adopted by the national securities exchange on which the Company&#8217;s  Common Stock is listed. Neither the Board nor the Committee shall offer a cash buy-out of &#8220;underwater&#8221; Options, and such buyouts of &#8220;underwater&#8221; Options shall be prohibited.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stock Appreciation Rights.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each SAR granted under the Plan shall be evidenced by an Award Agreement. Each SAR so granted shall be subject to the conditions set forth in this Section 8, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement. Any Option granted under the Plan may include tandem SARs. The Committee also may award SARs to Eligible Persons independent of any Option.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Strike Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided by the Committee in the case of Substitute Awards, the strike price (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Strike Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) per share of Common Stock for each SAR shall not be less than 100% of the Fair Market Value of such share (determined as of the Date of Grant). Notwithstanding the foregoing, a SAR granted in tandem with (or in substitution for) an Option previously granted shall have a Strike Price at least equal to the Exercise Price of the corresponding Option.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Vesting and Expiration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A SAR granted in connection with an Option shall become exercisable and shall expire according to the same vesting schedule and expiration provisions as the corresponding Option. A SAR granted independent of an Option shall vest and become exercisable and shall expire in such manner and on such date or dates determined by the Committee and shall expire after such period, not to exceed ten years, as may be determined by the Committee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SAR Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that notwithstanding any vesting dates set by the Committee, and consistent with the Committee&#8217;s power under Section 4(b), the Committee may, in its sole discretion, accelerate the exercisability of any SAR upon a Change in Control, death, Disability or Retirement (or on any other termination of employment) of a Participant, which acceleration shall not affect the terms and conditions of such SAR other than with respect to exercisability.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. SARs that have become exercisable may be exercised by delivery of written or electronic notice of exercise to the Company in accordance with the terms of the Award, specifying the number of SARs to be exercised and the date on which such SARs were awarded. Notwithstanding the foregoing, if on the last day of the Option Period (or in the case of a SAR independent of an Option, the SAR Period), the Fair Market Value exceeds the Strike Price, the Participant has not exercised the SAR or the corresponding Option (if applicable), and neither the SAR nor the corresponding Option (if applicable) has expired, such SAR shall be deemed to have been exercised by the Participant on such last day and the Company shall make the appropriate payment therefor.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the exercise of a SAR, the Company shall pay to the Participant an amount equal to the number of shares subject to the SAR that are being exercised multiplied by the excess, if any, of the Fair Market Value of one share of Common Stock on the exercise date over the Strike Price, less an amount equal to any federal, state, local and non-U.S. income and employment taxes required to be withheld. The Company shall pay such amount in cash, in shares of Common Stock valued at Fair Market Value, or any combination thereof, as determined by the Committee. Any fractional share of Common Stock shall be settled in cash.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Substitution of SARs for Nonqualified Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall have the authority in its sole discretion to substitute, without the consent of the affected Participant or any holder or beneficiary of SARs, SARs settled in shares of Common Stock (or settled in shares or cash in the sole discretion of the Committee) for outstanding Nonqualified Stock Options, provided that (i) the substitution shall not otherwise result in a modification of the terms of any such Nonqualified Stock Option, (ii) the number of shares of Common Stock underlying the substituted SARs shall be the same as the number of shares of Common Stock underlying such Nonqualified Stock Options and (iii) the Strike Price of the substituted SARs shall be equal to the Exercise Price of such Nonqualified Stock Options&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that if, in the opinion of the Company&#8217;s independent public auditors, the foregoing provision creates adverse accounting consequences for the Company, such provision shall be considered null and void.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Restricted Stock and Restricted Stock Units.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each grant of Restricted Stock and Restricted Stock Units shall be evidenced by an Award Agreement. Each Restricted Stock and Restricted Stock Unit grant shall be subject to the conditions set forth in this Section 9, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Stock Certificates and Book Entry&#59; Escrow or Similar Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the grant of Restricted Stock, the Committee shall cause a stock certificate registered in the name of the Participant to be issued or shall cause share(s) of Common Stock to be registered in the name of the Participant and held in book-entry form subject to the Company&#8217;s directions and, if the Committee determines that the Restricted Stock shall be held by the Company or in escrow rather than delivered to the Participant pending the release of the applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (i) an escrow agreement satisfactory to the Committee, if applicable, and (ii) the appropriate stock power (endorsed in blank) with respect to the Restricted Stock covered by such agreement. If a Participant shall fail to execute an agreement evidencing an Award of Restricted Stock and, if applicable, an escrow agreement and blank stock power within the amount of time specified by the Committee, the Award shall be null and void. Subject to the restrictions set forth in this Section 9 and the applicable Award Agreement, the Participant generally shall have the rights and privileges of a stockholder as to such Restricted Stock, including without limitation the right to vote such Restricted Stock. To the extent that shares of Restricted Stock are forfeited, any stock certificates issued to the Participant evidencing such shares shall be returned to the Company, and all rights of the Participant to such shares and as a stockholder with respect thereto shall terminate without further obligation on the part of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Vesting&#59; Acceleration of Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Restricted Period with respect to Restricted Stock and Restricted Stock Units shall lapse in such manner and on such date or dates determined by the Committee and the </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committee shall determine the treatment of the unvested portion of Restricted Stock and Restricted Stock Units upon termination of employment or service of the Participant granted the applicable Award. Consistent with the Committee&#8217;s power under Section 4(b), the Committee may in its sole discretion accelerate the lapse of any or all of the restrictions on the Restricted Stock and Restricted Stock Units upon a Change in Control, death, Disability or Retirement (or on any other termination of employment) of a Participant, which acceleration shall not affect any other terms and conditions of such Awards.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Delivery of Restricted Stock and Settlement of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Upon the expiration of the Restricted Period with respect to any shares of Restricted Stock, the restrictions set forth in the applicable Award Agreement shall be of no further force or effect with respect to such shares, except as set forth in the applicable Award Agreement. If an escrow arrangement is used, upon such expiration, the Company shall deliver to the Participant, or his or her beneficiary, without charge, the stock certificate (or, if applicable, a notice evidencing a book entry notation) evidencing the shares of Restricted Stock that have not then been forfeited and with respect to which the Restricted Period has expired (rounded down to the nearest full share). Dividends, if any, that may have been withheld by the Committee and attributable to any particular share of Restricted Stock shall be distributed to the Participant in cash or, at the sole discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to the amount of such dividends, upon the release of restrictions on such share and, if such share is forfeited, the Participant shall have no right to such dividends. Dividends and dividend equivalents credited or payable in connection with an Award of Restricted Stock that has not yet vested shall be subject to the same restrictions and risk of forfeiture as the underlying Award and shall not be paid until the underlying Award vests.  </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Unless otherwise provided by the Committee in the applicable Award Agreement, upon the expiration of the Restricted Period with respect to any outstanding Restricted Stock Units, the Company shall deliver to the Participant, or his or her beneficiary, without charge, one share of Common Stock (or other securities or other property, as applicable) for each such outstanding Restricted Stock Unit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Committee may, in its sole discretion, elect to (A) pay cash or part cash and part Common Stock in lieu of delivering only shares of Common Stock in respect of such Restricted Stock Units or (B) defer the delivery of Common Stock (or cash or part Common Stock and part cash, as the case may be) beyond the expiration of the Restricted Period. If a cash payment is made in lieu of delivering shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the Common Stock as of the date on which the Restricted Period lapsed with respect to such Restricted Stock Units. To the extent provided in the applicable Award Agreement, the holder of outstanding Restricted Stock Units shall be entitled to be credited with dividend equivalent payments (upon the payment by the Company of dividends on shares of Common Stock) either in cash or, at the sole discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to the amount of such dividends, upon the release of restrictions on such Restricted Stock Units, and, if such Restricted Stock Units are forfeited, the Participant shall have no right to such dividend equivalent payments.  Dividends and dividend equivalents credited or payable in connection with an Award of Restricted Stock Units that has not yet vested shall be subject to the same restrictions and risk of forfeiture as the underlying Award and shall not be paid until the underlying Award vests.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Legends on Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each certificate representing Restricted Stock awarded under the Plan, if any, shall bear a legend substantially in the form of the following, in addition to any other information the Company deems appropriate, until the lapse of all restrictions with respect to such Common Stock&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TRANSFER OF THIS CERTIFICATE AND THE SHARES REPRESENTED HEREBY IS RESTRICTED PURSUANT TO THE TERMS OF THE ATRICURE, INC. 2023 STOCK INCENTIVE PLAN AND A RESTRICTED STOCK AWARD AGREEMENT, BETWEEN ATRICURE, INC. AND PARTICIPANT. A COPY OF SUCH PLAN AND AWARD AGREEMENT IS ON FILE AT THE PRINCIPAL EXECUTIVE OFFICES OF ATRICURE, INC.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Stock-Based Awards.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may issue unrestricted Common Stock or rights under the Company&#8217;s other incentive programs that, subject to the terms and conditions thereof, provide for the right to receive grants of Awards at a future date, or other Awards denominated in Common Stock, under the Plan to Eligible Persons, alone or in tandem with other Awards, in such amounts as the Committee shall from time to time in its sole discretion determine. Each Other Stock-Based Award granted under the Plan shall be evidenced by an Award Agreement. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Other Stock-Based Award so granted shall be subject to such conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Non-Employee Director Awards.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee shall grant Awards to each Non-Employee Director as part of the retainer for Non-Employee Director service. The number of shares of Common Stock underlying the Awards granted to each Non-Employee Director shall be the number of shares of Common Stock equal to the award value divided by the Fair Market Value of a share of Common Stock on the Date of Grant. Notwithstanding the foregoing, the Committee may grant Options, Restricted Stock Units, Restricted Stock or other types of Awards contemplated by this Plan.  Subject to the limitations in Section 5(b)(iii), the Committee shall have the authority to establish the award value annually. As of the Effective Date of the Plan, the Committee has established the following&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Automatic Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Non-Employee Director shall automatically be granted (A) shares of Restricted Stock worth $175,000 of Common Stock, as valued on the Date of Grant, upon, or in connection with, commencement of service as a director of the Company, and (B) Restricted Stock worth $150,000 of Common Stock, as valued on the Date of Grant, at each annual meeting of the Company&#8217;s stockholders. All such Restricted Stock shall be subject to the terms and conditions of this Plan. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt;text-decoration:underline">Vesting of Restricted Stock Granted to Non-Employee Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each initial grant of Restricted Stock granted to a newly elected or appointed Non-Employee Director shall vest in three (3) successive equal annual installments over the Non-Employee Director&#8217;s period of continued service as a director, with the first such installment to vest upon the Non-Employee Director&#8217;s completion of one (1) year of service as a Non-Employee Director measured from the Date of Grant. Each annual grant of Restricted Stock granted to continuing Non-Employee Directors shall vest upon the Non-Employee Director&#8217;s completion of one (1) year of service as a Non-Employee Director measured from the Date of Grant.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Performance Compensation Awards.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall have the authority, at the time of grant of any Award described in Section 9 or 10 of the Plan, to designate such Award as a Performance Compensation Award. The Committee shall also have the authority to grant a standalone cash-based Performance Compensation Award pursuant to this Section 11.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Discretion of Committee with Respect to Performance Compensation Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With regard to a particular Performance Period, the Committee shall have sole discretion to select the length of such Performance Period, the type(s) of Performance Compensation Awards to be issued, the Performance Criteria that will be used to establish the Performance Goal(s), the kind(s) and&#47;or level(s) of the Performance Goals(s) that is (are) to apply, the Performance Formula, and the form of settlement for such Award. With regard to the Performance Compensation Awards to be issued for such Performance Period, the Committee may exercise its discretion with respect to each of the matters enumerated in the immediately preceding sentence and record the same in writing.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Performance Criteria</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Performance Criteria that will be used to establish the Performance Goal(s) may be based on the attainment of specific levels of performance of the Company (and&#47;or one or more Affiliates, divisions or operational units, or any combination of the foregoing) and may include, but shall not be limited to, the following&#58; (i) net earnings or net income (before or after taxes)&#59; (ii) basic or diluted earnings per share (before or after taxes)&#59; (iii) net revenue or net revenue growth&#59; (iv) gross revenue, gross revenue growth&#59; (v) gross profit or gross profit growth&#59; (vi) net operating profit (before or after taxes)&#59; (vii) return measures (including, but not limited to, stockholder return, TSR, return on investment, assets (including net assets), capital, invested capital, equity, or sales)&#59; (viii) cash flow measures (including, but not limited to, operating cash flow, free cash flow, and cash flow return on capital)&#59; (ix) earnings before or after taxes, interest, depreciation or amortization&#59; (x) gross or operating margins&#59; (xi) productivity ratios&#59; (xii) share price (including, but not limited to, growth measures and total stockholder return)&#59; (xiii) expense targets&#59; (xiv) operating efficiency&#59; (xv) objective measures of customer satisfaction&#59; (xvi) working capital targets&#59; (xvii) measures of economic value added&#59; (xviii) inventory control&#59; (xix) enterprise value&#59; (xx) sales&#59; (xxi) stockholder return&#59; (xxii)&#59; client retention&#59; (xxiii) competitive market metrics&#59; (xxiv) employee retention&#59; (xxv) timely completion of new product rollouts&#59; (xxvi) timely launch of new facilities&#59; (xxvii) objective measures of personal targets, goals or completion of projects (including, but not limited to, succession and hiring projects, completion of specific acquisitions, reorganizations or other corporate transactions, expansions of specific business operations and meeting divisional or project budgets)&#59; (xxviii) any other objective or subjective criteria, including individual performance criteria, as determined by the Committee&#59; or (xxix) any combination of the foregoing. Performance Criteria also may include measures related to environmental, social and&#47;or governance (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ESG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) matters, including, without limitation, matters related to people, retention, hiring, headcount, and diversity, equity and inclusion (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">DEI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Any one or more of the Performance Criteria may be used on an absolute, adjusted, or relative basis to measure the performance of the Company and&#47;or </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">one or more Affiliates as a whole or any divisional or operational unit(s) of the Company and&#47;or one or more Affiliates or any combination thereof, as the Committee may deem appropriate, or any of the above Performance Criteria may be compared to the performance of a selected group of comparison companies, or a published or special index that the Committee, in its sole discretion, deems appropriate, or as compared to various stock market indices. The Committee also has the authority to provide for accelerated vesting of any Award based on the achievement of Performance Goals pursuant to the Performance Criteria specified in this paragraph.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Modification of Performance Goal(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may alter Performance Criteria or modify the calculation of a Performance Goal without obtaining stockholder approval to reflect any event that would reasonably be expected to affect or alter such Performance Criteria or Performance Goal, including, but not limited to&#58; (i) asset write-downs&#59; (ii) litigation or claim judgments or settlements&#59; (iii) the effect of changes in tax laws, accounting principles, or other laws or regulatory rules affecting reported results&#59; (iv) any reorganization and restructuring programs&#59; (v) nonrecurring items&#59; (vi) acquisitions or divestitures&#59; (vii) any other specific unusual or infrequently occurring events, or objectively determinable category thereof&#59; (viii) foreign exchange gains and losses&#59; (ix) a change in the Company&#8217;s fiscal year&#59; or (x) any other event as determined by the Committee.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Payment of Performance Compensation Awards.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Condition to Receipt of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise provided in the applicable Participant Agreement, a Participant must be employed by the Company on the last day of a Performance Period to be eligible for payment in respect of a Performance Compensation Award for such Performance Period.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise provided in the applicable Participant Agreement, a Participant shall be eligible to receive payment in respect of a Performance Compensation Award only to the extent that (A) the Performance Goals for such period are achieved&#59; and (B) all or some of the portion of such Participant&#8217;s Performance Compensation Award has been earned for the Performance Period based on the application of the Performance Formula to such achieved Performance Goals.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt;text-decoration:underline">Use of Negative Discretion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In determining the actual amount of an individual Participant&#8217;s Performance Compensation Award for a Performance Period, the Committee may reduce or eliminate the amount of the Performance Compensation Award earned under the Performance Formula in the Performance Period through the use of Negative Discretion if, in its sole judgment, such reduction or elimination is appropriate.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Timing of Award Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise provided in the applicable Award Agreement, Performance Compensation Awards granted for a Performance Period shall be paid to Participants as soon as administratively practicable following the Committee&#8217;s determination of the amount earned. Unless otherwise provided in the applicable Award Agreement, any Performance Compensation Award that is otherwise payable in shares of Common Stock shall be credited (during the period between the Date of Grant and the payment date) with dividend equivalents (in a manner consistent with the methodology set forth in the last sentence of Section 9(d)(ii)).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Changes in Capital Structure and Similar Events.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Dilution and Other Adjustments.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  In the event of any merger, reorganization, consolidation, liquidation, recapitalization, reclassification, redesignation, stock dividend, other extraordinary distribution (whether in the form of cash, shares or otherwise), stock split,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reverse stock split, spin off, combination, repurchase or exchange of shares or issuance of warrants or rights to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase shares or other securities, or other change in corporate structure affecting the Common Stock of the Company, the Committee may make such adjustments in the aggregate number and type of shares which may be delivered and the individual award maximums as set forth in Section 5, the number and type of shares subject to outstanding Awards and the Exercise Price or other price of shares of Common Stock subject to outstanding Awards (provided the number of shares of Common Stock subject to any Award shall always be a whole number), as may be and to the extent determined to be appropriate and equitable by the Committee, in its sole discretion, to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan.  Such adjustment shall be conclusive and binding for all purposes of the Plan.  The Committee shall determine whether and the extent to which any recapitalization, extraordinary distribution, reclassification, repurchase or exchange of shares or other event requires any such adjustment.  Any such adjustment of an ISO or SAR shall be made in compliance with Code Sections 422 and 424, and no such adjustment shall be made that would cause any Award which is or becomes subject to Code Section 409A to fail to comply with the requirements of Code Section 409A or is exempt from Code Section 409A to become subject to Code Section 409A.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision of the Plan to the contrary, immediately upon the occurrence of a Change in Control, the following provisions of this Section 12(b) shall apply except to the extent that (A) the applicable Award is assumed or an equivalent option or right substituted by the successor corporation or a parent or subsidiary of the successor corporation&#59; or (B) an Award Agreement provides for a different treatment (in which case the Award Agreement shall govern)&#58; </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">all outstanding Options and SARs vest and become fully exercisable&#59; and </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">all Full-Value Awards become fully vested and all Performance Goals or other vesting criteria will be deemed achieved at target levels and all other terms and conditions met</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Termination by Death, Disability, or Retirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Subject to Section 14(b), if a Participant&#8217;s employment by the Company terminates by reason of death, Disability or Retirement, or in the case of an advisory relationship if such business relationship terminates by reason of death or Disability, any Award held by such Participant, unless otherwise determined by the Committee at grant or otherwise interpreted pursuant to Section 14(u) hereof, shall be fully vested and may thereafter be exercised by the Participant or by the Participant&#8217;s beneficiary or legal representative, for a period of one (1) year following termination of employment, in the case of death or Disability, and 90 days in the case of Retirement, or such longer period as the Committee may specify at or after grant in all cases other than ISOs, or until the expiration of the stated term of such Award, whichever period is shorter&#59; provided, that unless otherwise provided in an Award Agreement, for Full-Value Awards conditioned on achievement of Performance Goals, no vesting may occur and&#47;or no distribution may be made in the case of Retirement prior to the attainment of Performance Goals. </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt;text-decoration:underline">Termination for Cause.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If a Participant&#8217;s employment or service terminates for Cause, (A) all Options and SARs (or portions thereof) which have not been exercised, whether vested or not, and (B) all unvested Full-Value Awards, shall immediately be forfeited upon termination, including such Awards that are subject to performance conditions (or unearned portions thereof).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt;text-decoration:underline">Other Terminations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If a Participant&#8217;s employment or service terminates, voluntarily or involuntarily, for any reason other than death, Disability, Retirement or Cause, (A) any vested portion of Options or SARs held by the Participant at the time of termination may be exercised for a period of three months (or such other period as the Committee may specify at or after the time of grant) from the termination date, or until the expiration of the original term of the Option or SAR, whichever period is shorter, (B) no unvested portion of any Option or SAR shall become vested, including such Awards that are subject to performance conditions (or unearned portions thereof), and (C) all unvested Full-Value Awards, including such Awards that are subject to performance conditions (or unearned portions thereof), shall immediately be forfeited upon termination. </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt;text-decoration:underline">Limitation for ISOs.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No ISO may be exercised more than three months following termination of employment for any reason (including Retirement) other than death or Disability, nor more than one year following termination of employment for the reason of death or Disability (as defined in Code Section 422), or such Award will no longer qualify as an ISO and shall thereafter be, and receive the tax treatment applicable to, a NQSO. For this purpose, a termination of employment is cessation of employment, under the rules applicable to ISOs, such that no employment relationship exists between the Participant and the Company. </font></div><div style="margin-top:6pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Transfers and Leaves of Absence.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The transfer of a Participant within the Company shall not be deemed a termination of employment except as required by Sections 422 and 409A of the Code, and other applicable laws.  The following leaves of absences are not deemed to be a termination of employment&#58; </font></div><div style="margin-top:6pt;padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.28pt">if approved in writing by the Company, for military service, sickness or any other purpose approved by the Company, and the period of absence does not exceed 90 days&#59; </font></div><div style="margin-top:6pt;padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.84pt">if in excess of 90 days, if approved in writing by the Company, but only if the Participant&#8217;s right to reemployment is guaranteed by statute or contract and provided that the Participant returns to work within 30 days after the end of such absence&#59; and </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:144pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.84pt">subject to the restrictions of Section 409A of the Code and to the extent that such discretion is permitted by law, if the Committee determines in its discretion that the absence is not a termination of employment.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Amendments and Termination.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Amendment and Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board may amend, alter, suspend, discontinue, or terminate the Plan or any portion thereof at any time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no such amendment, alteration, suspension, discontinuation or termination shall be made without stockholder approval if such approval is necessary to comply with any regulatory requirement applicable to the Plan (including, without limitation, as necessary to comply with any rules or regulations of any securities exchange or inter-dealer quotation system on which the securities of the Company may be listed or quoted)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that any such amendment, alteration, suspension, discontinuance or termination that would materially and adversely affect the rights of any Participant or any holder or beneficiary of any Award theretofore granted shall not to that extent be effective without the consent of the affected Participant, holder or beneficiary. Notwithstanding the foregoing, no amendment shall be made to the last proviso of Section 13(b) without stockholder approval.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Amendment of Award Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may, to the extent consistent with the terms of any applicable Award Agreement, waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any Award theretofore granted or the associated Award Agreement, prospectively or retroactively&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would materially and adversely affect the rights of any Participant with respect to any Award theretofore granted shall not to that extent be effective without the consent of the affected Participant&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that without stockholder approval, except as otherwise permitted under Section 12 of the Plan, (i) no amendment or modification may reduce the Exercise Price of any Option or the Strike Price of any SAR, (ii) the Committee may not cancel any outstanding Option or SAR and replace it with a new Option or SAR (with a lower Exercise Price or Strike Price, as the case may be) or other Award or cash in a manner which would result in any &#8220;repricing&#8221; for financial statement reporting purposes (or otherwise cause the Award to fail to qualify for equity accounting treatment) and (iii) the Committee may not take any other action which is considered a &#8220;repricing&#8221; for purposes of the stockholder approval rules of any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or quoted.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">General.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Award Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Award under the Plan shall be evidenced by an Award Agreement, which shall be delivered to the Participant and shall specify the terms and conditions of the Award and any rules applicable thereto, including, without limitation, the effect on such Award of the death, Disability or termination of employment or service of a Participant, or of such other events as may be determined by the Committee. For purposes of the Plan, an Award Agreement may be in any such form (written or electronic) as determined by the Committee (including, without limitation, a Board or Committee resolution, an employment agreement, a notice, a certificate or a letter) evidencing the Award. The Committee need not require an Award Agreement to be signed by the Participant or a duly authorized representative of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Minimum Vesting Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of the Plan to the contrary, Awards granted under the Plan (other than cash-based Awards) shall vest no earlier than the first anniversary of the date on which the Award is granted&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the following Awards shall not be subject to the foregoing minimum vesting requirement&#58; any (i) Substitute Awards, (ii) Shares delivered in lieu of fully vested cash Awards, (iii) Awards to Eligible Directors that vest on the earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year&#8217;s annual meeting, and (iv) any additional Awards the Committee may grant, up to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section 5(b) (subject to adjustment under Section 12)&#59; and, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the foregoing restriction does not apply to the Committee&#8217;s discretion to provide for accelerated exercisability or vesting of any Award, including in cases of Retirement, death, Disability or a Change in Control, in the terms of the Award or otherwise.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Nontransferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Each Award shall be exercisable only by a Participant during the Participant&#8217;s lifetime, or, if permissible under applicable law, by the Participant&#8217;s legal guardian or representative. No Award may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Participant other than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or an Affiliate&#59; provided, that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Notwithstanding the foregoing, the Committee may, in its sole discretion, permit Awards (other than Incentive Stock Options) to be transferred by a Participant, without consideration, subject to such rules as the Committee may adopt consistent with any applicable Award Agreement to preserve the purposes of the Plan, to (A) any person who is a &#8220;family member&#8221; of the Participant, as such term is used in the instructions to Form S-8 under the Securities Act (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Immediate Family Members</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; (B) a trust solely for the benefit of the Participant and his or her Immediate Family Members&#59; (C) a partnership or limited liability company whose only partners or stockholders are the Participant and his or her Immediate Family Members&#59; or (D) any other transferee as may be approved either (1) by the Board or the Committee, as applicable, in its sole discretion, or (2) as provided in the applicable Award Agreement (each transferee described in clause (A), (B), (C) or (D) above is hereinafter referred to as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Permitted Transferee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) provided that the Participant gives the Committee advance written notice describing the terms and conditions of the proposed transfer and the Committee notifies the Participant in writing that such a transfer would comply with the requirements of the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The terms of any Award transferred in accordance with the immediately preceding sentence shall apply to the Permitted Transferee, and any reference in the Plan, or in any applicable Award Agreement, to a Participant shall be deemed to refer to the Permitted Transferee, except that (A) Permitted Transferees shall not be entitled to transfer any Award, other than by will or the laws of descent and distribution&#59; (B) Permitted Transferees shall not be entitled to exercise any transferred Option unless there shall be in effect a registration statement on an appropriate form covering the shares of Common Stock to be acquired pursuant to the exercise of such Option if the Committee determines, consistent with any applicable Award Agreement, that such a registration statement is necessary or appropriate&#59; (C) the Committee or the Company shall not be required to provide any notice to a Permitted Transferee, whether or not such notice is or would otherwise have been required to be given to the Participant under the Plan or otherwise&#59; and (D) the consequences of the termination of the Participant&#8217;s employment by, or services to, the Company or an Affiliate under the terms of the Plan and the applicable Award Agreement shall continue to be applied with respect to the Participant, including, without limitation, that an Option shall be exercisable by the Permitted Transferee only to the extent, and for the periods, specified in the Plan and the applicable Award Agreement.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Dividends and Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee in its sole discretion may provide a Participant as part of an Award with dividends or dividend equivalents, payable in cash, shares of Common Stock, other securities, other Awards or other property, on a current or deferred basis, on such terms and conditions as may be determined by the Committee in its sole discretion, including, without limitation, payment directly to the Participant, withholding of such amounts by the Company subject to vesting of the Award or reinvestment in additional shares of Common Stock, Restricted Stock or other Awards. However, dividends and dividend equivalents credited or payable in connection with an Award that has not yet vested shall be subject to the same restrictions and risk of forfeiture as the underlying Award and shall not be paid until the underlying Award vests.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Tax Withholding.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">A Participant shall be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right and is hereby authorized to withhold, from any cash, shares of Common Stock, other securities or other property deliverable under any Award or from any compensation or other amounts owing to a Participant, the amount (in cash, Common Stock, other securities or other property) of any required withholding taxes in respect of an Award, its exercise, or any payment or transfer under an Award or under the Plan and to take such other action as may be necessary in the opinion of the Committee or the Company to satisfy all obligations for the payment of such withholding and taxes.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Without limiting the generality of clause  (i)  above, the Committee may, in its sole discretion, permit a Participant to satisfy, in whole or in part, the foregoing withholding liability (but no more than the maximum required statutory withholding liability) by (A)  the delivery of shares of Common Stock (which are not subject to any pledge or other security interest) owned by the Participant having a Fair Market Value equal to such withholding liability or (B)  having the Company withhold from the number of shares of Common Stock otherwise issuable or deliverable pursuant to the exercise or settlement of the Award a number of shares with a Fair Market Value equal to such withholding liability.  A Participant may elect to satisfy such withholding liability through cash or cash proceeds.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">No Claim to Awards&#59; No Rights to Continued Employment&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee of the Company or an Affiliate, or other person, shall have any claim or right to be granted an Award under the Plan or, having been selected for the grant of an Award, to be selected for a grant of any other Award. There is no obligation for uniformity of treatment of Participants or holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee&#8217;s determinations and interpretations with respect thereto need not be the same with respect to each Participant and may be made selectively among Participants, whether or not such Participants are similarly situated. Neither the Plan nor any action taken hereunder shall be construed as giving any Participant any right to be retained in the employ or service of the Company or an Affiliate, nor shall it be construed as giving any Participant any rights to continued service on the Board. The Company or any of its Affiliates may at any time dismiss a Participant from employment or discontinue any consulting relationship, free from any liability or any claim under the Plan, unless otherwise expressly provided in the Plan or any Award Agreement. By accepting an Award under the Plan, a Participant shall thereby be deemed to have waived any claim to continued exercise or vesting of an Award or to damages or severance entitlement related to non-continuation of the Award beyond the period provided under the Plan or any Award Agreement, notwithstanding any provision to the contrary in any written employment contract or other agreement between the Company and its Affiliates and the Participant, whether any such agreement is executed before, on or after the Date of Grant.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">International Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to Participants who reside or work outside of the United States of America, the Committee may in its sole discretion amend the terms of the Plan or Sub Plans or outstanding Awards with respect to such Participants in order to conform such terms with the requirements of local law or to obtain more favorable tax or other treatment for a Participant, the Company or its Affiliates.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Designation and Change of Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Participant may file with the Committee a written designation of one or more persons as the beneficiary or beneficiaries, as applicable, who shall be entitled to receive the amounts payable with respect to an Award, if any, due under the Plan upon his or her death. A Participant may, from time to time, revoke or change his or her beneficiary designation without the consent of any prior beneficiary by filing a new designation with the Committee. The last such designation received by the Committee shall be controlling&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no designation, or change or revocation thereof, shall be effective unless received by the Committee prior to the Participant&#8217;s death, and in no event shall it be effective as of a date prior to such receipt. If no beneficiary designation is filed by a Participant, the beneficiary shall be deemed to be his or her spouse or, if the Participant is unmarried at the time of death, his or her estate.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise provided in the applicable Participant Agreement, unless determined otherwise by the Committee at any point following such event&#58; (i) neither a temporary absence from employment or service due to illness, vacation or leave of absence nor a transfer from employment or service with the Company to employment or service with an Affiliate (or vice-versa) shall be considered a termination of employment or service of such Participant with the Company or an Affiliate&#59; and (ii) if a Participant&#8217;s employment with the Company and its Affiliates terminates, but such Participant continues to provide services to the Company and its Affiliates in a non-employee capacity, such change in status shall not be considered a termination of employment or service of such Participant with the Company or an Affiliate for purposes of the Plan.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">No Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise specifically provided in the Plan or any Award Agreement, no person shall be entitled to the privileges of ownership in respect of shares of Common Stock that are subject to Awards hereunder until such shares have been issued or delivered to that person.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Government and Other Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The obligation of the Company to settle Awards in Common Stock or other consideration shall be subject to all applicable laws, rules, and regulations, and to such approvals by governmental agencies as may be required. Notwithstanding any terms or conditions of any Award to the contrary, the Company shall be under no obligation to offer to sell or to sell, and shall be prohibited from offering to sell or selling, any shares of Common Stock pursuant to an Award unless such shares have been properly registered for sale pursuant to the Securities Act with the Securities and Exchange Commission or unless the Company has received an opinion of counsel, satisfactory to the Company, that such shares may be offered or sold without such registration pursuant to an available exemption therefrom and the terms and conditions of such exemption have been fully complied with. The Company shall be under no obligation to register for sale under the Securities Act any of the shares of Common Stock to be offered or sold under the Plan. The Committee shall have the authority to provide that all shares of Common Stock or other securities of the Company or any Affiliate delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan, the applicable Award </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement, the federal securities laws, or the rules, regulations and other requirements of the Securities and Exchange Commission, any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or quoted and any other applicable federal, state, local or non-U.S. laws, and, without limiting the generality of Section 9 of the Plan, the Committee may cause a legend or legends to be put on certificates representing shares of Common Stock or other securities of the Company or any Affiliate delivered under the Plan to make appropriate reference to such restrictions or may cause such Common Stock or other securities of the Company or any Affiliate delivered under the Plan in book-entry form to be held subject to the Company&#8217;s instructions or subject to appropriate stop-transfer orders. Notwithstanding any provision in the Plan to the contrary, the Committee reserves the right to add any additional terms or provisions to any Award granted under the Plan that it in its sole discretion deems necessary or advisable in order that such Award complies with the legal requirements of any governmental entity to whose jurisdiction the Award is subject.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The Committee may cancel an Award or any portion thereof if it determines, in its sole discretion, that legal or contractual restrictions, blockage, other market considerations or any combination of the foregoing would make the Company&#8217;s acquisition of shares of Common Stock from the public markets, the Company&#8217;s issuance of Common Stock to the Participant, the Participant&#8217;s acquisition of Common Stock from the Company or the Participant&#8217;s sale of Common Stock to the public markets, illegal, impracticable or inadvisable. If the Committee determines to cancel all or any portion of an Award in accordance with the foregoing, the Company shall pay to the Participant an amount equal to the excess of (A) the aggregate Fair Market Value of the shares of Common Stock subject to such Award or portion thereof canceled (determined as of the applicable exercise date, or the date that the shares would have been vested or delivered, as applicable), over (B) the aggregate Exercise Price or Strike Price (in the case of an Option or SAR, respectively) or any amount payable as a condition of delivery of shares of Common Stock (in the case of any other Award). Such amount shall be delivered to the Participant as soon as practicable following the cancellation of such Award or portion thereof.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">No Section 83(b) Elections Without Consent of Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No election under Section 83(b) of the Code or under a similar provision of law may be made unless expressly permitted by the terms of the applicable Award Agreement or by action of the Committee in writing prior to the making of such election. If a Participant, in connection with the acquisition of shares of Common Stock under the Plan or otherwise, is expressly permitted to make such election and the Participant makes the election, the Participant shall notify the Company of such election within ten days of filing notice of the election with the Internal Revenue Service or other governmental authority, in addition to any filing and notification required pursuant to Section 83(b) of the Code or other applicable provision.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt;text-decoration:underline">Payments to Persons Other Than Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Committee shall find that any person to whom any amount is payable under the Plan is unable to care for his or her affairs because of illness or accident, or is a minor, or has died, then any payment due to such person or his or her estate (unless a prior claim therefor has been made by a duly appointed legal representative) may, if the Committee so directs the Company, be paid to his or her spouse, child, relative, an institution maintaining or having custody of such person, or any other person deemed by the Committee to be a proper recipient on behalf of such person otherwise entitled to payment. Any such payment shall be a complete discharge of the liability of the Committee and the Company therefor.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Nonexclusivity of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither the adoption of this Plan by the Board nor the submission of this Plan to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of stock options otherwise than under this Plan, and such arrangements may be either applicable generally or only in specific cases.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">No Trust or Fund Created</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate, on the one hand, and a Participant or other person or entity, on the other hand. No provision of the Plan or any Award shall require the Company, for the purpose of satisfying any obligations under the Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or otherwise to segregate any assets, nor shall the Company maintain separate bank accounts, books, records or other evidence of the existence of a segregated or separately maintained or administered fund for such purposes. Participants shall have no rights under the Plan other than as unsecured general creditors of the Company, except that insofar as they may have become entitled to payment of additional compensation by performance of services, they shall have the same rights as other employees under general law.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">p.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Reliance on Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each member of the Committee and each member of the Board shall be fully justified in acting or failing to act, as the case may be, and shall not be liable for having so acted or failed to act in good faith, in reliance upon any report made by the independent public accountant of the Company and its Affiliates and&#47;or any other information furnished in connection with the Plan by any agent of the Company or the Committee or the Board, other than himself.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Relationship to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No payment under the Plan shall be taken into account in determining any benefits under any pension, retirement, profit sharing, group insurance or other benefit plan of the Company except as otherwise specifically provided in such other plan.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall be governed by and construed in accordance with the internal laws of the State of Delaware applicable to contracts made and performed wholly within the State of Delaware, without giving effect to the conflict of laws provisions thereof.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.61pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All disputes and claims of any nature that a Participant (or such Participant&#8217;s transferee or estate) may have against the Company arising out of or in any way related to the Plan or any Award Agreement shall be submitted to and resolved exclusively by binding arbitration conducted in Hamilton County, Ohio (or such other location as the parties thereto may agree) in accordance with the applicable rules of the American Arbitration Association then in effect, and the arbitration shall be heard and determined by a panel of three arbitrators in accordance with such rules (except that in the event of any inconsistency between such rules and this Section 14(s), the provisions of this Section 14(s) shall control). The arbitration panel may not modify the arbitration rules specified above without the prior written approval of all parties to the arbitration. Within ten (10) business days after the receipt of a written demand, each party shall designate one arbitrator, each of whom shall have experience involving complex business or legal matters, but shall not have any prior, existing or potential material business relationship with any party to the arbitration. The two arbitrators so designated shall select a third arbitrator, who shall preside over the arbitration, shall be similarly qualified as the two arbitrators and shall have no prior, existing or potential material business relationship with any party to the arbitration&#59; provided that if the two arbitrators are unable to agree upon the selection of such third arbitrator, such third arbitrator shall be designated in accordance with the arbitration rules referred to above. The arbitrators will decide the dispute by majority decision, and the decision shall be rendered in writing and shall bear the signatures of the arbitrators and the party or parties who shall be charged therewith. The arbitration decision shall be rendered as soon as possible, but in any event not later than 120 days after the constitution of the arbitration panel. The arbitration decision shall be final and binding upon all parties to the arbitration. The parties hereto agree that judgment upon any award rendered by the arbitration panel may be entered in the United States District Court for the Southern District of Ohio or any court sitting in Hamilton County, Ohio. To the maximum extent permitted by law, the parties hereby irrevocably waive any right of appeal from any judgment rendered upon any such arbitration award in any such court. Notwithstanding the foregoing, any party may seek injunctive relief in any such court.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any provision of the Plan or any Award or Award Agreement is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any person or entity or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be construed or deemed stricken as to such jurisdiction, person or entity or Award and the remainder of the Plan and any such Award shall remain in full force and effect.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">u.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Statute of Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant or any other person filing a claim for benefits under the Plan or an Award must file the claim within one (1) year of the date the Participant or other person knew or should have known of the facts giving rise to the claim. This one-year statute of limitations will apply in any forum where a Participant or any other person may file a claim and, unless the Company waives the time limit set forth above in its sole discretion, any claim not brought within the time period specified shall be waived and forever barred.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Obligations Binding on Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The obligations of the Company under the Plan shall be binding upon any successor corporation or organization resulting from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">w.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.28pt;text-decoration:underline">409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms of the Plan, the Committee may determine that all or a portion of any Award to a Participant, whether it is to be paid in cash, Common Stock or a combination thereof, shall be deferred or may, in its sole discretion, approve deferral elections made by Participants.  Deferrals shall be for such periods and upon such terms as the Committee may determine in its sole discretion, which terms shall comply with Section 409A of the Code. Each Award granted under the Plan is intended to be either exempt from or in </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compliance with the requirements of Section 409A of the Code, and all provisions of this Plan shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A of the Code. Each Participant is solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on or in respect of such Participant in connection with this Plan or any other plan maintained by the Company (including any taxes and penalties under Section 409A of the Code), and neither the Company nor any Affiliate shall have any obligation to indemnify or otherwise hold such Participant (or any beneficiary) harmless from any or all of such taxes or penalties. If a Participant is a Specified Employee at the time of the Participant&#8217;s Separation from Service with the Company, then solely to the extent necessary to avoid the imposition of any additional tax under Section 409A of the Code, the commencement of any payments or benefits under an Award (which Award is subject to Section 409A of the Code and otherwise provides for the commencement of payments or benefits upon Separation from Service) shall be deferred until the date that is six months following the Participant&#8217;s Separation from Service (or such other period as required to comply with Section 409A of the Code).</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Clawback&#47;Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary contained herein, a Participant Agreement may provide that the Committee may in its sole discretion cancel such Award if the Participant, without the consent of the Company, while employed by or providing services to the Company or any Affiliate or after termination of such employment or service, violates a non-competition, non-solicitation or non-disclosure covenant or agreement or otherwise engages in activity that is in conflict with or adverse to the interest of the Company or any Affiliate, including fraud or conduct contributing to any financial restatements or irregularities, as determined by the Committee in its sole discretion. A Participant Agreement may also provide that if the Participant engages in any activity referred to in the preceding sentence, the Participant will forfeit any gain realized on the vesting or exercise of such Award, and must repay the gain to the Company. In addition, any Award shall be subject to forfeiture or repayment pursuant to the terms of any applicable compensation recoupment or recovery policy adopted by the Company, Committee or Board, as thereafter amended, including any policy adopted to comply with the rules of any national securities exchange on which the Company&#8217;s Common Stock is traded or the Securities and Exchange Commission.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Section 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that satisfies, the applicable requirements of Rule 16b-3 as promulgated under Section 16 of the Exchange Act so that Participants will be entitled to the benefit of Rule 16b-3, or any other rule promulgated under Section 16 of the Exchange Act, and will not be subject to short-swing liability under Section 16 of the Exchange Act. Accordingly, if the operation of any provision of the Plan would conflict with the intent expressed in this Section 14(w), such provision to the extent possible shall be interpreted and&#47;or deemed amended so as to avoid such conflict.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">z.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a condition of receipt of any Award, each Participant explicitly and unambiguously consents to the collection, use, and transfer, in electronic or other form, of personal data as described in this Section 14(z) by and among, as applicable, the Company and its Affiliates for the exclusive purpose of implementing, administering, and managing the Plan and Awards and the Participant&#8217;s participation in the Plan. In furtherance of such implementation, administration, and management, the Company and its Affiliates may hold certain personal information about a Participant, including, but not limited to, the Participant&#8217;s name, home address, telephone number, date of birth, social security or insurance number or other identification number, salary, nationality, job title(s), information regarding any securities of the Company or any of its Affiliates, and details of all Awards (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). In addition to transferring the Data amongst themselves as necessary for the purpose of implementation, administration, and management of the Plan,  Awards, and the Participant&#8217;s participation in the Plan, the Company and its Affiliates may each transfer the Data to any third parties assisting the Company in the implementation, administration, and management of the Plan and Awards and the Participant&#8217;s participation in the Plan. Recipients of the Data may be located in the Participant&#8217;s country or elsewhere, and the Participant&#8217;s country and any given recipient&#8217;s country may have different data privacy laws and protections. By accepting an Award, each Participant authorizes such recipients to receive, possess, use, retain, and transfer the Data, in electronic or other form, for the purposes of assisting the Company in the implementation, administration, and management of the Plan and Awards and the Participant&#8217;s participation in the Plan. The Data related to a Participant will be held only as long as is necessary to implement, administer, and manage the Plan and Awards and the Participant&#8217;s participation in the Plan. A Participant may, at any time, view the Data held by the Company with respect to such Participant, request additional information about the storage and processing of the Data with respect to such Participant, recommend any necessary corrections to the Data with respect to the Participant, or refuse or withdraw the consents herein in writing, in any case without cost, by contacting his or her local human resources representative. The Company may cancel the Participant&#8217;s eligibility to participate in the Plan, and in the Committee&#8217;s discretion, the Participant may forfeit any outstanding Awards if the Participant refuses or withdraws the consents described herein. For more information on the consequences of refusal to consent or withdrawal of consent, Participants may contact their local human resources representative.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aa.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.64pt;text-decoration:underline">Participants Outside of the United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may modify the terms of any Award under the Plan made to or held by a Participant who is then a resident, or is primarily employed or providing services, outside of the United States in any manner deemed by the Committee to be necessary or appropriate in order that such Award shall conform to laws, regulations, and customs of the country in which the Participant is then a resident or primarily employed or providing services, or so that the value and other benefits of the Award to the Participant, as affected by non&#8211;U.S. tax laws and other restrictions applicable as a result of the Participant&#8217;s residence, employment, or providing services abroad, shall be comparable to the value of such Award to a Participant who is a resident, or is primarily employed or providing services, in the United States. An Award may be modified under this Section 14(aa) in a manner that is inconsistent with the express terms of the Plan, so long as such modifications will not contravene any applicable law or regulation or result in actual liability under Section 16(b) of the Exchange Act for the Participant whose Award is modified. Additionally, the Committee may adopt such procedures as are necessary or appropriate to permit participation in the Plan by Eligible Persons who are non&#8211;U.S. nationals or are primarily employed or providing services outside the United States.</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ab.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.07pt;text-decoration:underline">Expenses&#59; Gender&#59; Titles and Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The expenses of administering the Plan shall be borne by the Company and its Affiliates. Masculine pronouns and other words of masculine gender shall refer to both men and women. The titles and headings of the sections in the Plan are for convenience of reference only, and in the event of any conflict, the text of the Plan, rather than such titles or headings shall control.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a2018employeestockpurchase.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if04ba3303ee94b00a05cc7911697f68b_33"></div><div style="min-height:45pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ATRICURE, INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2018 EMPLOYEE STOCK PURCHASE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(AMENDED AND RESTATED EFFECTIVE MAY 25, 2023)</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Purpose.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purposes of the Plan are as follows&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">To assist employees of the Company and its Participating Subsidiaries (as defined below) with the opportunity to acquire stock ownership interest in the Company.  The Plan is intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended, and the Plan will be administered and interpreted in accordance with that intent&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To help employees provide for their future security and to encourage them to remain in the employment of the Company&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">To help align the interests of our employees with those of the Company&#8217;s shareholders.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Definitions.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board or Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company, as constituted from time to time.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">Any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The consummation of the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; or </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its Parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the U.S. Internal Revenue Code of 1986, as it may be amended from time to time. Any reference to a section of the Code shall be deemed to include a reference to any regulations promulgated thereunder.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the committee appointed by the Board to administer the Plan.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the common stock of the Company, par value $0.001 per share.  &#8220;Common Stock&#8221; shall also include (i) the common stock of the surviving corporation in any consolidation, merger or reincorporation effected exclusively to change the domicile of the Company and (ii) such other securities of the Company that may be substituted for Common Stock pursuant to Section 18 hereof.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means AtriCure, Inc., a Delaware corporation, or any successor corporation (including, without limitation, the surviving corporation in any consolidation, merger or reincorporation effected exclusively to change the domicile of the Company).</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all base straight time gross earnings, non-worked paid hours (PTO, VTO, Holiday, Bereavement, Jury, Excused Paid Time Off, and Parental Leave), annual bonuses as may be elected by an Eligible Employee, and commissions, exclusive of payments for overtime, shift premium, fringe benefits and other compensation paid to an Eligible Employee by the Company or a Participating Subsidiary as compensation for services to the Company or Participating Subsidiary, before deduction for any salary deferral contributions made by the Eligible Employee to any tax-qualified or nonqualified deferred compensation plan.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Designated Broker</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the financial services firm or other agent designated by the Company to maintain ESPP Share Accounts on behalf of Participants who have purchased shares of Common Stock under the Plan.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date as of which this Plan is adopted by the Board, subject to the Plan obtaining shareholder approval in accordance with Section 19.11 hereof.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person who renders services to the Company or a Participating Subsidiary as an employee pursuant to an employment relationship with such employer.  For purposes of the Plan, the employment relationship shall </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be treated as continuing intact while the individual is on military leave, sick leave or other leave of absence approved by the Company or a Participating Subsidiary that meets the requirements of Treasury Regulation Section 1.421-1(h)(2).  Where the period of leave exceeds three (3) months, or such other period of time specified in Treasury Regulation Section 1.421-1(h)(2), and the individual&#8217;s right to re-employment is not guaranteed by statute or contract, the employment relationship shall be deemed to have terminated on the first day immediately following such three-month period, or such other period specified in Treasury Regulation Section 1.421-1(h)(2).</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Employee of the Company&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">who does not, immediately after the option is granted, own stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company, a Parent or a Subsidiary (as determined under Section 423(b)(3) of the Code)&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">whose customary employment is for more than twenty (20) hours per week&#59; and </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">whose customary employment is for more than five (5) months in any calendar year.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of clause (i), the rules of Section 424(d) of the Code with regard to the attribution of stock ownership shall apply in determining the stock ownership of an individual, and stock which an employee may purchase under outstanding options shall be treated as stock owned by the employee.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Committee may exclude from participation in the Plan any Employee who is a &#8220;highly compensated employee&#8221; of the Company or a Participating Subsidiary (within the meaning of Section 414(q) of the Code) or a sub-set of such highly compensated employees.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enrollment Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an agreement pursuant to which an Eligible Employee may elect to enroll in the Plan, to authorize a new level of payroll deductions, or to stop payroll deductions and withdraw from an Offering Period.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESPP Share Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an account into which Common Stock purchased with accumulated payroll deductions at the end of an Offering Period are held on behalf of a Participant.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means as of any date, the value of Common Stock determined as follows&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">If the Common Stock is listed on any established stock exchange or a national market system, its Fair Market Value shall be the closing sales price for a share of Common Stock as reported in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (or such other source as the Committee may deem reliable for such purposes) for such date, or if no sale occurred on such date, the closing sales price on the first trading date immediately prior to such date during which a sale occurred&#59; </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">If the Common Stock is not traded on any established stock exchange or a national market system but is quoted on a quotation system, its Fair Market Value shall be the mean between the closing representative bid and asked prices for the Common Stock on such date, or if no sale occurred on such date, the first date immediately prior to such date on which sales prices or bid and asked prices, as applicable, are reported by such quotation system&#59; or </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">In the absence of an established market for the Common Stock, the Fair Market Value thereof shall be determined in good faith by the Committee.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Offering Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the first Trading Day of each Offering Period as designated by the Committee.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Offering or Offering Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each period of approximately six (6) months commencing on any January 1 and July 1 and terminating on the last Trading Day on or before the next occurring June 30 or December  31, as applicable, except for the first Offering Period under the Plan, which shall commence on the Effective Date and end on December 31, 2018.  The duration and timing of Offering Periods may be changed pursuant to Section 4 of this Plan, but in no event may an Offering Period have a duration in excess of twenty-seven (27) months.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation, other than the Company, in an unbroken chain of corporations ending with the Company if, at the time of the determination, each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Eligible Employee who is actively participating in the Plan.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participating Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Subsidiaries that have been designated as eligible to participate in the Plan, and such other Subsidiaries that may be designated by the Committee from time to time in its sole discretion.  The </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Committee may designate, or terminate the designation of, a subsidiary as a Participating Subsidiary without the approval of the shareholders of the Company.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this AtriCure, Inc. 2018 Employee Stock Purchase Plan, as set forth herein, and as amended from time to time.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the last Trading Day of each Offering Period.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means 85% of the Fair Market Value of a share of Common Stock on the Offering Date or on the Purchase Date, whichever is lower&#59; provided, however that (i) if the Committee so designates, the Committee may set from time to time for future Offering Periods a higher percentage of Fair Market Value of a share of Common Stock or a higher dollar amount as the Purchase Price or instead provide that the Purchase Price will be calculated based only on a percentage of the Fair Market Value of a share of Common Stock on the Purchase Date that is equal to or more than 85%&#59; (ii) the Purchase Price may be adjusted by the Committee pursuant to Section 18 hereof&#59; and (iii) the Purchase Price shall in no event be less than the par value of a share of Common Stock.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Act of 1933, as amended.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation, domestic or foreign, of which not less than 50% of the combined voting power is held by the Company or a Subsidiary, whether or not such corporation exists now or is hereafter organized or acquired by the Company or a Subsidiary.  In all cases, the determination of whether an entity is a Subsidiary shall be made in accordance with Section 424(f) of the Code.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any day on which the national stock exchange upon which the Common Stock is listed is open for trading or, if the Common Stock is not listed on an established stock exchange or national market system, a business day, as determined by the Committee in good faith.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Administration.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Plan shall be administered by the Committee which shall have the authority to construe and interpret the Plan, prescribe, amend and rescind rules relating to the Plan&#8217;s administration and take any other actions necessary or desirable for the administration of the Plan.  The Committee may correct any defect or supply any omission or reconcile any inconsistency or ambiguity in the Plan.  The decisions of the Committee shall be final and binding on all persons.  All expenses of administering the Plan shall be paid by the Company. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The Committee at its option may utilize the services of an agent to assist in the administration of the Plan including establishing and maintaining an individual securities account under the Plan for each Participant.  In its absolute discretion, the Board may at any time and from time to time exercise any and all rights and duties of the Committee under the Plan. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">All expenses and liabilities incurred by the Committee in connection with the administration of the Plan shall be borne by the Company.  The Committee may, with the approval of the Board, employ attorneys, consultants, accountants, appraisers, brokers or other persons.  The Committee, the Company and its officers and directors shall be entitled to rely upon the advice, opinions or valuations of any such persons.  All actions taken and all interpretations and determinations made by the Committee in good faith shall be final and binding upon all Participants, the Company and all other interested persons.  No member of the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or the options, and all members of the Board shall be fully protected by the Company in respect to any such action, determination, or interpretation.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Eligibility.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise determined by the Committee in a manner that is consistent with Section 423 of the Code, any individual who is an Eligible Employee as designated by the Committee for a particular Offering Period shall be eligible to participate in such Offering Period, subject to the requirements of Section 423 of the Code.  Notwithstanding any provision of the Plan to the contrary, no Eligible Employee shall be granted an option under the Plan if such option would permit his or her rights to purchase stock under all employee stock purchase plans (described in Section 423 of the Code) of the Company and its Subsidiaries to accrue at a rate that exceeds $25,000 of the Fair Market Value of such stock (determined at the time the option is granted) for each calendar year in which such option is outstanding at any time.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Offering Periods.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan shall be implemented by a series of consecutive Offering Periods, each of which shall be six (6) months in duration, with new Offering Periods commencing on or about January 1 and July 1 of each year (or such other times as </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determined by the Committee).  The Committee shall have the authority to change the duration, frequency, start and end dates of Offering Periods.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Participation.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Custom Enrollment&#59; Payroll Deductions.  An Eligible Employee may elect to participate in the Plan by properly completing an Enrollment Form, which may be electronic, and submitting it to the Company, in accordance with the enrollment procedures established by the Committee.  Participation in the Plan is entirely voluntary. By submitting an Enrollment Form, the Eligible Employee authorizes payroll deductions from his or her pay check in an amount equal to at least 1%, but not more than 10% of his or her Compensation on each pay day occurring during an Offering Period (or such other maximum percentage as the Committee may establish from time to time before an Offering Period begins).  Payroll deductions shall commence on the first payroll date following the Offering Date and end on the last payroll date on or before the Purchase Date.  The Company shall maintain records of all payroll deductions but shall have no obligation to pay interest on payroll deductions or to hold such amounts in a trust or in any segregated account.  Unless expressly permitted by the Committee, a Participant may not make any separate contributions or payments to the Plan. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Election Changes.  During an Offering Period, a Participant may decrease or increase his or her rate of payroll deductions applicable to such Offering Period.  The Committee may limit the number of election changes made by a Participant in an Offering Period.  To make such a change, the Participant must submit a new Enrollment Form authorizing the new rate of payroll deductions at least five (5) business days before the Purchase Date. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Automatic Re-enrollment.  The deduction rate selected in the Enrollment Form shall remain in effect for subsequent Offering Periods unless the Participant (a) submits a new Enrollment Form authorizing a new level of payroll deductions in accordance with Section 6, (b) withdraws from the Plan in accordance with Section 10, or (c) terminates employment or otherwise becomes ineligible to participate in the Plan.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Grant of Option.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On each Offering Date, each Participant in the applicable Offering Period shall be granted an option to purchase, on the Purchase Date, a number of shares of Common Stock determined by dividing the Participant&#8217;s accumulated payroll deductions by the applicable Purchase Price&#59; provided, however, that in no event shall any Participant purchase more than 2,500 shares of Common Stock during an Offering Period (subject to adjustment in accordance with Section 18 and the limitations set forth in Section 13 of the Plan).</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exercise of Option&#47;Purchase of Shares.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant&#8217;s option to purchase shares of Common Stock will be exercised automatically on the Purchase Date of each Offering Period.  The Participant&#8217;s accumulated payroll deductions will be used to purchase the maximum number of whole shares that can be purchased with the amounts in the Participant&#8217;s notional account.  No fractional shares may be purchased but notional fractional shares of Common Stock will be allocated to the Participant&#8217;s ESPP Share Account to be aggregated with other notional fractional shares of Common Stock on future Purchase Dates, subject to earlier withdrawal by the Participant in accordance with Section 10 or termination of employment in accordance with Section 11.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Transfer of Shares.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As soon as reasonably practicable after each Purchase Date, the Company will arrange for the delivery to each Participant of the shares of Common Stock purchased upon exercise of his or her option.  The Committee may permit or require that the shares be deposited directly into an ESPP Share Account established in the name of the Participant with a Designated Broker and may require that the shares of Common Stock be retained with such Designated Broker for a specified period of time.  Participants will not have any voting, dividend or other rights of a shareholder with respect to the shares of Common Stock subject to any option granted hereunder until such shares have been delivered pursuant to this Section 9.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Withdrawal.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Withdrawal Procedure.  A Participant may withdraw from an Offering by submitting to the Company a revised Enrollment Form indicating his or her election to withdraw at least five (5) days before the Purchase Date.  The accumulated payroll deductions held on behalf of a Participant in his or her notional account (that have not been used to purchase shares of Common Stock) shall be paid to the Participant promptly following receipt of the Participant&#8217;s Enrollment Form indicating his or her election to withdraw and the Participant&#8217;s option shall be automatically terminated.  If a Participant withdraws from </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an Offering Period, no payroll deductions will be made during any succeeding Offering Period, unless the Participant re-enrolls in accordance with Section 6 of the Plan. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Effect on Succeeding Offering Periods.  A Participant&#8217;s election to withdraw from an Offering Period will not have any effect upon his or her eligibility to participate in succeeding Offering Periods that commence following the completion of the Offering Period from which the Participant withdraws.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Termination of Employment&#59; Change in Employment Status.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon termination of a Participant&#8217;s employment for any reason, including death, disability or retirement, or a change in the Participant&#8217;s employment status following which the Participant is no longer an Eligible Employee, which in either case occurs before the Purchase Date, the Participant will be deemed to have withdrawn from the Plan and the payroll deductions in the Participant&#8217;s notional account (that have not been used to purchase shares of Common Stock) shall be returned to the Participant, or in the case of the Participant&#8217;s death, to the person(s) entitled to such amounts under Section 17, and the Participant&#8217;s option shall be automatically terminated</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No interest shall accrue on or be payable with respect to the payroll deductions of a Participant in the Plan.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Shares Reserved for Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Number of Shares.  The maximum number of shares of Common Stock reserved as authorized for the grant of options under the Plan is 1,250,000 shares.  If any right granted under the Plan shall for any reason terminate without having been exercised, the Common Stock not purchased under such right shall again become available for issuance under the Plan.  In addition, any unused shares reserved under the AtriCure, Inc. 2008 Employee Stock Purchase Plan shall become available for issuance under this Plan and if any right granted under the AtriCure, Inc. 2008 Employee Stock Purchase Plan shall for any reason terminate without having been exercised, the Common Stock not purchased under such right shall become available for issuance under this Plan. The shares of Common Stock may be newly issued shares, treasury shares or shares acquired on the open market.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Over-subscribed Offerings.  The number of shares of Common Stock which a Participant may purchase in an Offering under the Plan may be reduced if the Offering is over-subscribed.  No option granted under the Plan shall permit a Participant to purchase shares of Common Stock which, if added together with the total number of shares of Common Stock purchased by all other Participants in such Offering would exceed the total number of shares of Common Stock remaining available under the Plan.  If the Committee determines that, on a particular Purchase Date, the number of shares of Common Stock with respect to which options are to be exercised exceeds the number of shares of Common Stock then available under the Plan, the Company shall make a pro rata allocation of the shares of Common Stock remaining available for purchase in as uniform a manner as practicable and as the Committee determines to be equitable.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Transferability.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No payroll deductions credited to a Participant, nor any rights with respect to the exercise of an option or any rights to receive Common Stock hereunder may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution, or as provided in Section 17 hereof) by the Participant.  Any attempt to assign, transfer, pledge or otherwise dispose of such rights or amounts shall be without effect.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Application of Funds.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All payroll deductions received or held by the Company under the Plan may be used by the Company for any corporate purpose to the extent permitted by applicable law, and the Company shall not be required to segregate such payroll deductions or contributions.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Statements.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participants will be provided with statements at least annually which shall set forth the contributions made by the Participant to the Plan, the Purchase Price of any shares of Common Stock purchased with accumulated funds, the number of shares of Common Stock purchased, and any payroll deduction amounts remaining in the Participant&#8217;s notional account.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Designation of Beneficiary.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">A Participant may file, on forms supplied by the Committee, a written designation of beneficiary who is to receive any shares of Common Stock and cash in respect of any fractional shares of Common Stock, if </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any, from the Participant&#8217;s ESPP Share Account under the Plan in the event of such Participant&#8217;s death.  In addition, a Participant may file a written designation of beneficiary who is to receive any cash withheld through payroll deductions and credited to the Participant&#8217;s notional account in the event of the Participant&#8217;s death prior to the Purchase Date of an Offering Period.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Such designation of a beneficiary may be changed by the Participant at any time by written notice to the Company.  In the event of the death of a Participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such Participant&#8217;s death, the Company shall deliver such shares and&#47;or cash to the executor or administrator of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares and&#47;or cash to the spouse or to any one or more dependents or relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Adjustments Upon Changes in Capitalization&#59; Dissolution or Liquidation&#59; Change in Control.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Changes in Capitalization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to any required action by the shareholders of the Company, the number of shares of Common Stock which have been authorized for issuance under the Plan but not yet placed under option, the maximum number of shares each Participant may purchase during each Offering Period (pursuant to Section 7 hereof), as well as the price per share and the number of shares of Common Stock covered by each option under the Plan which has not yet been exercised shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other increase or decrease in the number of shares of Common Stock effected without receipt of consideration by the Company&#59; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been &#8220;effected without receipt of consideration.&#8221; Such adjustment shall be made by the Committee, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to an option.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Dissolution or Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of the proposed dissolution or liquidation of the Company, the Offering Period then in progress shall be shortened by setting a new Exercise Date (the &#8220;New Exercise Date&#8221;), and shall terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the Committee.  The New Exercise Date shall be before the effective date of the Company&#8217;s proposed dissolution or liquidation.  The Committee shall notify each Participant in writing, at least ten (10) business days prior to the New Exercise Date, that the Exercise Date for the Participant&#8217;s option has been changed to the New Exercise Date and that the Participant&#8217;s option shall be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the Offering Period as provided in Section 10 hereof.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Merger or Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of a merger or Change in Control, the Offering Period with respect to each outstanding option will be shortened by setting a New Exercise Date and will end on the New Exercise Date.  The New Exercise Date will occur before the date of the Company&#8217;s proposed merger or Change in Control.  The Committee will notify each Participant in writing, at least ten (10) business days prior to the New Exercise Date, that the Exercise Date for the Participant&#8217;s option has been changed to the New Exercise Date and that the Participant&#8217;s option will be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the Offering Period as provided in Section 10 hereof.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">General Provisions.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Equal Rights and Privileges.  Notwithstanding any provision of the Plan to the contrary and in accordance with Section 423 of the Code, all Eligible Employees who are granted options under the Plan shall have the same rights and privileges.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">No Right to Continued Service.  Neither the Plan nor any compensation paid hereunder will confer on any Participant the right to continue as an Employee or in any other capacity.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Rights as Shareholder.  A Participant will become a shareholder with respect to the shares of Common Stock that are purchased pursuant to options granted under the Plan when the shares are transferred to the Participant&#8217;s ESPP Share Account.  A Participant will have no rights as a shareholder with respect to shares of Common Stock for which an election to participate in an Offering Period has been made until such Participant becomes a shareholder as provided above.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Successors and Assigns.  The Plan shall be binding on the Company and its successors and assigns.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Entire Plan.  This Plan constitutes the entire plan with respect to the subject matter hereof and supersedes all prior plans with respect to the subject matter hereof.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Compliance with Law.  The obligations of the Company with respect to payments under the Plan are subject to compliance with all applicable laws and regulations.  Common Stock shall not be issued with respect to an option granted under the Plan unless the exercise of such option and the issuance and delivery of the shares of Common Stock pursuant thereto shall comply with all applicable provisions of law, including, without limitation, the Securities Act, the Exchange Act, and the requirements of any stock exchange upon which the shares of Common Stock may then be listed.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Notice of Disqualifying Dispositions.  Each Participant shall give the Company prompt written notice of any disposition or other transfer of shares of Common Stock acquired pursuant to the exercise of an option acquired under the Plan, if such disposition or transfer is made within two years after the Offering Date or within one year after the Purchase Date.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Term of Plan.  The Plan shall become effective on the Effective Date and, unless terminated earlier pursuant to Section 19.9, shall have a term of ten (10) years.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Amendment or Termination.  The Committee may, in its sole discretion, amend, suspend or terminate the Plan at any time and for any reason.  If the Plan is terminated, the Committee may elect to terminate all outstanding Offering Periods either immediately or once shares of Common Stock have been purchased on the next Purchase Date (which may, in the discretion of the Committee, be accelerated) or permit Offering Periods to expire in accordance with their terms (and subject to any adjustment in accordance with Section 18).  If any Offering Period is terminated before its scheduled expiration, all amounts that have not been used to purchase shares of Common Stock will be returned to Participants (without interest, except as otherwise required by law) as soon as administratively practicable.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Applicable Law.  The laws of the State of Delaware shall govern all questions concerning the construction, validity and interpretation of the Plan, without regard to such state&#8217;s conflict of law rules.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Shareholder Approval.  The Plan shall be subject to approval by the shareholders of the Company within twelve (12) months before or after the date the Plan is adopted by the Board.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Section 423.  The Plan is intended to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Code.  Any provision of the Plan that is inconsistent with Section 423 of the Code shall be reformed to comply with Section 423 of the Code.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Withholding.  To the extent required by applicable Federal, state or local law, a Participant must make arrangements satisfactory to the Company for the payment of any withholding or similar tax obligations that arise in connection with the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Severability.  If any provision of the Plan shall for any reason be held to be invalid or unenforceable, such invalidity or unenforceability shall not affect any other provision hereof, and the Plan shall be construed as if such invalid or unenforceable provision were omitted.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Headings.  The headings of sections herein are included solely for convenience and shall not affect the meaning of any of the provisions of the Plan.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>atrc-20230525.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c03a66db-4b53-4956-9adb-aa31c32e1f2a,g:8ec2bafd-d900-45a9-907f-a72c4a0b0840-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:atrc="http://www.atricure.com/20230525" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.atricure.com/20230525">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="atrc-20230525_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="atrc-20230525_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.atricure.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>atrc-20230525_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c03a66db-4b53-4956-9adb-aa31c32e1f2a,g:8ec2bafd-d900-45a9-907f-a72c4a0b0840-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_e32c8fde-aa89-416d-b8c2-f7ea1825e313_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_11f7949c-8ea7-4c0f-b0bc-6d0f8f915e0b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c994b6c2-a8ae-475a-adea-7114fc1ff731_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9bbf97c1-2644-40af-b9a8-d208ccd47ca1_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1bc069a2-68fe-408c-b2fc-5c6fddbf62dc_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_06fd1027-f669-403c-afc0-5cdbf2b97b60_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ebc54fd3-aac7-4327-9786-9e669acbc4f4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_5111bbb6-ed21-4099-835f-2c93b42ff8f8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_920eddcb-5bb3-450d-8c26-9135aef58aa4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f2741a5a-7021-4abf-995b-8d82201028e1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_a1e9f4c9-da4a-404b-85e8-b1465ebc3aa3_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_841a8152-b6a3-4ae3-b5bc-6632d275676d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e78f9126-35d5-4b19-8abb-86f3902ec227_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9b3b618d-832b-4d63-9633-22f5e4da8dd3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e783bfcd-41cd-4444-88c4-d3d185d4c160_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ebe04581-0d3a-4c05-b26b-e9d3d121f51d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2576edf8-3efa-441d-8f4a-f915bdbba4a8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b7f66fdc-5d5f-4ceb-9964-97d204385acc_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0418576d-dda5-42a4-8cbb-4474f8806d80_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ecd74df1-0d9e-4392-9e14-2404cf43499d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_36832dd0-890f-4d86-bf72-4104e939af99_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9a767da7-2ae1-42cd-a9a1-c3cfccf1f479_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>atrc-20230525_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:c03a66db-4b53-4956-9adb-aa31c32e1f2a,g:8ec2bafd-d900-45a9-907f-a72c4a0b0840-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.atricure.com/role/Cover" xlink:type="simple" xlink:href="atrc-20230525.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.atricure.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f280846d-ec33-4be9-a8cb-7c49c412ea63" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_DocumentType_f280846d-ec33-4be9-a8cb-7c49c412ea63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e1d40ec6-06da-4f5c-9ee8-98f7d3f0a067" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_DocumentPeriodEndDate_e1d40ec6-06da-4f5c-9ee8-98f7d3f0a067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4488e98a-4576-442b-b2df-d0208dbda322" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityRegistrantName_4488e98a-4576-442b-b2df-d0208dbda322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5538a45b-3d0d-4c97-93dc-abeac5fadfbb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5538a45b-3d0d-4c97-93dc-abeac5fadfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f1c19eb0-ecb8-46cc-8552-9474d7d6ed69" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityFileNumber_f1c19eb0-ecb8-46cc-8552-9474d7d6ed69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6a2bb0a8-00a3-4caf-acc5-72c80a4cbfb1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityTaxIdentificationNumber_6a2bb0a8-00a3-4caf-acc5-72c80a4cbfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b463a5bc-dfe4-4ce5-8e14-ddc136644d85" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityAddressAddressLine1_b463a5bc-dfe4-4ce5-8e14-ddc136644d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b9642508-c582-458d-8a24-26d16db93e52" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityAddressCityOrTown_b9642508-c582-458d-8a24-26d16db93e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_834265e1-066c-4199-a5b1-4936a596ed7e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityAddressStateOrProvince_834265e1-066c-4199-a5b1-4936a596ed7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_99eda155-af0f-4f76-bf5b-402db1dfd384" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityAddressPostalZipCode_99eda155-af0f-4f76-bf5b-402db1dfd384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a75cf0df-1b19-4b16-b2d8-061ae3f87033" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_CityAreaCode_a75cf0df-1b19-4b16-b2d8-061ae3f87033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_81ae1d8c-e669-4804-925f-11fb6bed0eed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_LocalPhoneNumber_81ae1d8c-e669-4804-925f-11fb6bed0eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d4973637-a66e-4afb-b4cd-03ba4a17e5f3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_WrittenCommunications_d4973637-a66e-4afb-b4cd-03ba4a17e5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_40525ac9-888f-42b1-a41a-6f7a14285bd1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_SolicitingMaterial_40525ac9-888f-42b1-a41a-6f7a14285bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4dda034e-dc4d-4b6d-bfc1-212067b42a14" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_PreCommencementTenderOffer_4dda034e-dc4d-4b6d-bfc1-212067b42a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_2e44f7c2-8463-41f0-996a-d77d8785d06e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_2e44f7c2-8463-41f0-996a-d77d8785d06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f98d35f6-00fa-45b7-ad36-5980ba5e50b9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_Security12bTitle_f98d35f6-00fa-45b7-ad36-5980ba5e50b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_245a7883-c8e2-4b7c-ba4e-7530091489de" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_TradingSymbol_245a7883-c8e2-4b7c-ba4e-7530091489de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fd567b1e-59b8-4a99-b13e-ccf950fc56aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_SecurityExchangeName_fd567b1e-59b8-4a99-b13e-ccf950fc56aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b15999f7-9181-487c-82b1-120576d6807b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityEmergingGrowthCompany_b15999f7-9181-487c-82b1-120576d6807b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7eca2f0e-f039-4505-8750-d305261e6d2c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_EntityCentralIndexKey_7eca2f0e-f039-4505-8750-d305261e6d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6697a5be-0316-416b-88a5-438d2fc4aba8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_66a2f73e-9dff-4a4a-b629-e15ea161fe6d" xlink:to="loc_dei_AmendmentFlag_6697a5be-0316-416b-88a5-438d2fc4aba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140028542937040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 25, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 25,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AtriCure, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">34-1940305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7555 Innovation Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mason<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">45040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">755-4100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATRC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001323885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>atrc-20230525_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="atrc-20230525.xsd" xlink:type="simple"/>
    <context id="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001323885</identifier>
        </entity>
        <period>
            <startDate>2023-05-25</startDate>
            <endDate>2023-05-25</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV80L2ZyYWc6ZjNjZDljMzkyMTdmNDhjODljNzNjY2I3NDQ5MDU1ZDYvdGFibGU6YmU4OGY5MGNmOGU3NGM2NWJlNDdmOTQ1M2Q4ZmFlOGYvdGFibGVyYW5nZTpiZTg4ZjkwY2Y4ZTc0YzY1YmU0N2Y5NDUzZDhmYWU4Zl8wLTEtMS0xLTk3MzY0_41b935d1-8603-4b62-940d-c010376944da">0001323885</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV80L2ZyYWc6ZjNjZDljMzkyMTdmNDhjODljNzNjY2I3NDQ5MDU1ZDYvdGFibGU6YmU4OGY5MGNmOGU3NGM2NWJlNDdmOTQ1M2Q4ZmFlOGYvdGFibGVyYW5nZTpiZTg4ZjkwY2Y4ZTc0YzY1YmU0N2Y5NDUzZDhmYWU4Zl8xLTEtMS0xLTk3MzY0_5e4b4a72-df4a-4c20-ac82-1a83d5b59057">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzM5_72e6a226-9033-441f-bc10-f944d40cdfc7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQx_5c9effac-c8fe-4bab-bd79-0e85d7277ac6">2023-05-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ2_77090069-9121-46d6-86d7-ab7e74da266d">AtriCure, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6Y2FmM2M2ZmUxNmM1NGRkYzgxNGY4NGZjZjQxNGIwZTQvdGFibGVyYW5nZTpjYWYzYzZmZTE2YzU0ZGRjODE0Zjg0ZmNmNDE0YjBlNF8wLTAtMS0xLTk3MzY0_ebdba026-c721-4f81-9549-98c3386df86b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6Y2FmM2M2ZmUxNmM1NGRkYzgxNGY4NGZjZjQxNGIwZTQvdGFibGVyYW5nZTpjYWYzYzZmZTE2YzU0ZGRjODE0Zjg0ZmNmNDE0YjBlNF8wLTEtMS0xLTk3MzY0_19dce32e-f8f2-45c4-b413-c83e16a942d8">000-51470</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6Y2FmM2M2ZmUxNmM1NGRkYzgxNGY4NGZjZjQxNGIwZTQvdGFibGVyYW5nZTpjYWYzYzZmZTE2YzU0ZGRjODE0Zjg0ZmNmNDE0YjBlNF8wLTItMS0xLTk3MzY0_e394d5ee-18d5-4712-be26-b7af6f14be8b">34-1940305</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ3_db273bb9-0148-4654-9211-a07c5870bb52">7555 Innovation Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQy_011b9767-882b-4306-be15-122e2df2fea5">Mason</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ4_f8b905f4-9d04-4e6d-bc46-27ff51e81d7f">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQz_ed31c27d-67ed-46c3-8208-3e5a70b71046">45040</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ0_d7eed439-4ea5-4573-bbe4-23423573b505">513</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ1_8cfddc88-aacb-4430-ba14-8e54a6dbe2ea">755-4100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6ODA0YzQ1YTMxYTY1NDVjMWExMjM0MzkzMDE2MzMwNDMvdGFibGVyYW5nZTo4MDRjNDVhMzFhNjU0NWMxYTEyMzQzOTMwMTYzMzA0M18wLTAtMS0xLTk3MzY0_c5c62b68-35da-47d1-94b4-fe4ee8d75065">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6ODA0YzQ1YTMxYTY1NDVjMWExMjM0MzkzMDE2MzMwNDMvdGFibGVyYW5nZTo4MDRjNDVhMzFhNjU0NWMxYTEyMzQzOTMwMTYzMzA0M18xLTAtMS0xLTk3MzY0_d65efd47-2750-4fa2-899e-bdf2cba7bdd4">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6ODA0YzQ1YTMxYTY1NDVjMWExMjM0MzkzMDE2MzMwNDMvdGFibGVyYW5nZTo4MDRjNDVhMzFhNjU0NWMxYTEyMzQzOTMwMTYzMzA0M18yLTAtMS0xLTk3MzY0_a48ee985-2dfc-49e7-9aed-2bb35ce35199">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6ODA0YzQ1YTMxYTY1NDVjMWExMjM0MzkzMDE2MzMwNDMvdGFibGVyYW5nZTo4MDRjNDVhMzFhNjU0NWMxYTEyMzQzOTMwMTYzMzA0M18zLTAtMS0xLTk3MzY0_7945027c-7aae-48b8-8fc2-35cee810d256">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6NmE0YzlkOGMwYzhkNGRlYmI3ZWFlYjAzZWNlMGM2ZWMvdGFibGVyYW5nZTo2YTRjOWQ4YzBjOGQ0ZGViYjdlYWViMDNlY2UwYzZlY18xLTAtMS0xLTk3MzY0_24476094-cedb-4ae3-bd57-1c28df087e69">Common Stock, $.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6NmE0YzlkOGMwYzhkNGRlYmI3ZWFlYjAzZWNlMGM2ZWMvdGFibGVyYW5nZTo2YTRjOWQ4YzBjOGQ0ZGViYjdlYWViMDNlY2UwYzZlY18xLTEtMS0xLTk3MzY0_75a38c50-062c-4808-b025-f06cf2634408">ATRC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGFibGU6NmE0YzlkOGMwYzhkNGRlYmI3ZWFlYjAzZWNlMGM2ZWMvdGFibGVyYW5nZTo2YTRjOWQ4YzBjOGQ0ZGViYjdlYWViMDNlY2UwYzZlY18xLTItMS0xLTk3MzY0_27e21111-a9dd-4430-85cf-4fa741ec0fba">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525"
      id="id3VybDovL2RvY3MudjEvZG9jOmFkODY5ZDFmZTE3YTRlMjNiZmUyNGM3MDMwNzg3YTVlL3NlYzphZDg2OWQxZmUxN2E0ZTIzYmZlMjRjNzAzMDc4N2E1ZV8xL2ZyYWc6MTFkODQwYjlkMzU5NGFmNGEwMTc1N2NiZjMzZWJhMmIvdGV4dHJlZ2lvbjoxMWQ4NDBiOWQzNTk0YWY0YTAxNzU3Y2JmMzNlYmEyYl8xMzQ5_9ec2abe5-1300-4e31-bd78-92f4eded31de">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MKL"EU?8TN^T8F9<GR)DT<!XMFTM&P1[L"_!\+J79=^RAM/J?PN!_4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ >5ZZ5IE<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" !Y7KI6'3VFA3$$  !?$   &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ >5ZZ5I^@&_"Q @  X@P   T
M             ( !=0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !Y7KI6
MEXJ[',     3 @  "P              @ %1#P  7W)E;',O+G)E;'-02P$"
M% ,4    " !Y7KI6JL0B%C,!   B @  #P              @ $Z$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ >5ZZ5B0>FZ*M    ^ $  !H
M         ( !FA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ >5ZZ5F60>9(9 0  SP,  !,              ( !?Q(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  R1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="atrc-20230525.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.atricure.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="atrc-20230525.htm">atrc-20230525.htm</File>
    <File>a2018employeestockpurchase.htm</File>
    <File>a2023stockincentiveplan.htm</File>
    <File>atrc-20230525.xsd</File>
    <File>atrc-20230525_lab.xml</File>
    <File>atrc-20230525_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "atrc-20230525.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "atrc-20230525.htm"
     ]
    },
    "labelLink": {
     "local": [
      "atrc-20230525_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atrc-20230525_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "atrc-20230525.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "atrc",
   "nsuri": "http://www.atricure.com/20230525",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "atrc-20230525.htm",
      "contextRef": "ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.atricure.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "atrc-20230525.htm",
      "contextRef": "ie21e687f28c541b5ac72556e9741f4e5_D20230525-20230525",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.atricure.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001323885-23-000053-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001323885-23-000053-xbrl.zip
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M?FY.=,_G=\'GC,X8#DMS.EQW?8T 6$*A:N",&:93Y$B5DJ*PWH\54CX97Z:
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M6S0\BWVNSA]RQVP[XMX3O<]R'\ 2'\,T/.M<8T/!W(%;FH;?-HI'OA&7NM=
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MO0D'-?#'Y#436A3MDG59?-JX""!+:W0[!:>3>;R(G_PP%#%QD8,]5?Z7(Q*
M;./V*7_$]Y=+1.&6]%V1I?/ ,M!../LK=+9 0JQ%2,21#G0.WH]%I(UKD> 4
M0=PQ"MO/UA9DNEJ9.2+EP/184X[?!G-P-Z9Y(_O06:?1@8@#PN)C)0!A #0>
M@+Z;&OPWQKX-A4C2'.XR.+2J*2_A7*&[QB S-+[K"D-0\,'$G_1>V_HF-O7N
MV2E9,FP?TN D<C2*[C"P=-?&68T7IONFJ'$#NPF >4/-OHQP[Z2N'H%A9N6&
M0^X4_ NAAQ17<TGP%%W#Z6^2EWE1@,2U@:]'#[X[97!<LK$E#53O0S]<-V75
M)+Z:0\)I^MQY*#%^(I9!)[CAP#33 O0,'RX&[M&"\M-0(V"PT^6'T/+)Y$AW
M1AWK(;M7Q0@KV451LR[PF'>&,CA=]/<EU8#"KH*=V5!9BH-%!D:9 @662DFW
M$)C=$[#[=BCKE.<28214S;?U57H?P+"BSE1]'@#QZ<FX-==R-(KK3B =<%>,
MQQ!F4Q(D.J99W^.Q:PQO7-C2Q]\]>\*N"R8]T*PE+%!?:N0(?FSKUN0L40Y'
M\L]5" BF![@POX_L>SL4=>^RR7S6MA  $PQUC86(=,R7#:@<?"0?.%9KULZV
M8W49FTI4GXR<LMX5W1\>'?ZV]7#[G,_,&8S]!%_<G^";G6"I'QC/,4ZDY!/K
M]K3?6%\AZJ!89ZBPE-M)I;WK=9$*^,+7\JGL:XR9S%R.AK\_9IZG"!*4&WC3
MD^X=^W]R982O*%2)O178XA@8MQ4"F*_W "OZM0L+!A!C?S>!L> Q;T!%9\I@
MF1M.#[:&MJ?'=SRA,Y<>&?WYM36CXSG"$F+$D56,S/^O!T</'ARC/R8UX&O4
M<5CZ&K<-S@.GF G"WU,6P_XI.]7N0-MG64"$]V8I-^1^D-;V"B.YI/ED3P_3
M;_>'Z::'"7?@>,Y1R) !9F#TTF18]6'"(-064W8O-_;'\6SLNV#DO90P_X]8
MN#">W4VA'AJ:+E*EZ@H*32Z":),G1(A=V(\5 ]TCJ:Q81[ P%Y*!\T:7V9]R
M1&\_CT0VGB-Q)V3]2X<['L.!Z!O#-)E]7)8%C/E0AK.@__WPM0;'I_0VIX>S
M!!1*-EBC20ASMW!1"!9RN,N3 S,Y>#C1 9K8UP4P/%32X F3_Y"0J70NY_7Y
MVRH.*^SQ1YA30*@NZ%;B.DHVWC]SA=Z)&BU32N%;J'&;3RD2$&%V?09[D\,^
M%)%N\I10]?@S"POFPH&Z*-$BAB]HJ,F\6-<]- !=_AI-V<0$A-T0NQJ;S$Q6
MX(4(^U+?$;=-3_PY]YQ+>RI=5Z.1KD_O@G -RXO'(&"W61R68XX.!..ZUB@N
M_/'21&!?IG!N[!L^'\V&OQ,6=KCAHW,,;$0_@> >A;E](?%2X6>1.@N%[,T5
M?\%T7Z,AQ?V6OM&6AD5,L<C%8K+&L)-MAD!8=A#PE@I=DTV"H]EDJ30= LO^
MWI4E^<, XIQAYD^FAP\5B89&FI,]1H64H"GD.9KTK_T8?Y<2;DTJX\WI^<O3
M_V/KP#H131N+E&"E*6%5D@RN^4]3U)PMJ#95;5:AZ@HH V$F,DQ\4,03?R>N
MLINNE3&U($"B"H13EI2ZA$F&'0:2\ 6XY-%F$?=4/*SOQ<-GB8=WM+=&)!PP
MA2"5W0+^%''0+M5H^RZJ7MH>:"[@)H;>'8Z/+O3U]+UT%9/WMC"@[=^3+),(
M%CS1((.ND@]P_.!H4]EE@*!*W#<L(T!6\%F&/UZA)QF='SY3\NC<WQ+DFJ]@
MQ2K>%EZ6Z]-!#I"C29[?@J=!U7MC),Z4EUBPR=7L5O3&;@X=QW$\,#$="CP!
M[RDB7\H),<1+EV(JV(.O*)ME" )CK6 YUWA=&"E6H+=]04*M@O],8?[RH(:=
MQF-!%7,&(-(KMG&\W8%.D.ZMB-OQ!5L.W#^T2QE93#-.S.\6@^D"H)ZU "=,
M%@?FUZ3HIMA"92R=M?P GH36!P=DO'.#W'_&2/6UFPJ7#:\$^TV%_K8 MP[0
M,%NTP'U5R\VK6L:N'?]SKQUOI!V5\3@>U=A2 (&%2Q"YAX^^.$3NP-J0($U7
M3;9,'%7=I&MF[X+1H3'= ;3=%$T7R8C^(*JN=RQ[#JXKQR,%[D1!_MDG4\X0
MQ/6N!/-A#(+@!J&@IP?3@,IR3_=T-9X]?7STY'CT>_I5DI;1STGYT=31OQ'*
M-89M[6F[.X1@7?RDXLRF<@X^ Y@7B*ENTI+># 57\#=<.0B.4D\,A_.&2.=#
MOD."$: U"@#E0OH;ET9X:2Q34IG"<=JHB- U CZ49BR3.=^&CC._CR!?26WC
M]18"RT7O.7L ?"D3%DCZ#P&WR+AKR/\)<R:,J>!;7)$;PF_@JD<'Y@]K<=0<
M@N+=-HO4,".M)) 5<0.;G:&QA(=.8YLF52I)W.32E G>4W&"V@6:IG-9'K('
MJH_REUZ8/WE&>R93N>;I=6=T^WRZH. ?G<M5T6#,<_A<X0.613%'3BAT[8GF
MJ&82MS):L>QPK8#:+W84O0Z]9TS'#_!&=X21-B&WCJ^=>0\+G$ZPKPAR/ LR
M .<JGSO*)O/)K-8U>]@]161_UJBP[&H_E7 ]'B5\)]!+KYHL.^2M-2X2^.N2
MLE>D+)"2TGT9R("]W.7->';Y70BBO+:5VB!0\<'1SUQ9,X;-KE@+M3M5F5J8
MQ)4C=?SH8#;9SQT]'J('NZ-'3R338\>,84.#-![WS)V_'<,TN88$O'*")K4I
ME:07DLF),=\N4^J:^ :$8460YS1$L8()&E08$RF#<VHQD\^!G(""-! _+FZS
MEY+G:C22Y]G1R;/QZU+XYPK;?27CRMG?1(\^.C!A0'(O-_:GT6SL.V$D,JYJ
M/%N9&C5AJ;@ OG[,BFF2P1[&C+H$!?9SXV[N-^Z--B[VZ27$L*LG&=DN9N9&
M5^RB.A+;EA"2\K6-7ON,'_C:9%S!(CC">3-C88_#8VZB[4W8]O.X_#Z>XW(G
M6M,,M@@<PZD9<@LP0+_;->CW"O=SVR?C:8_\Y.C)H[NP[0_/+)Q]C%!\IKL)
M680%EX^[7T%">Q&T&U4[N)\;?CQ-;9_<!3D_0J'>UPK6H63VWR--QM-(]4Z(
M;+$!WA%=^A@V\HU 7[._0(PE&4]'T[LAD^O>!MICV-O7$M+'#_X">WH\O4[O
MA)16C>5&M8];A76NV"<LS.F+LPQ4Z@@'B:T6<F=E3X_!>)K&/3UZ>J>.P0A;
MO\<]'8#;)X0;7&[I\QO47/LZ/U>." L6:YI)+F>D3@ 2BBRXO6AE$$:*04K?
MHU,C2MM'M]VJLU7R&;NNH(//65-3EG59@%Y;\?5EB6A.S:L_5%&::N!P>VQ*
M6%1[*@G&0^9^)XR\[4'X,8@$E9N@P-$5431;VJU94ET<3LDZQ3-$QBK]&>\,
MP>Y(0 05U\ZF//X+V)3C85._>T>H3*D=],@.#@'K>6A<"BE_)+YA29ODG(W.
M3O-A4]6@;M/JPG+*Z;?_L4BR@VI"/PJ/%X=%>O3Z9M<I]"P&>WSBQD. _NQH
M_#AXO6.0[J+)1G;>XL$3P,4T16Y\NUEJIX0NVH)?Q:?5DV62YE4MB+_,7*(R
M:I\W/$:NOL19SDL\.K:9^O8#1KEX-@P;Y 92OH%7L_!F<505*^.Z"&&A%A7=
M<1<T_)Z[VOO>@MN?Z]Q;DY2Y]!AL_XPG;?C0WY-.[!_I1#(> ON[)@Q1'HRH
M4.*FHG")P_<61B_1[6<(B3M]&,9#>G_G;/'QI.):EKC>\]Q>F?EEB;=9LG9^
MRR,]&!OCH&$O3:G".TE=@X5@HT+ZMAVIP*URIY0.K)I2Z5NQ[HD16NP(H@O4
MAH#K9$2*" R+V(6Y?._$^"^*Z4O&P\)_1Q06[>QY]*&$!R"AT"C8)&Y<W/<7
MB 2-AP']X=W8V>,NL.F!@'3; @QUWCVR-]]/,H)D/.3G=\/2 JDWAJUN2>[2
M=N.LZ.3!R4/!5GNL]3O*K7FZNV[KC#T5Y>,A0K\;VQO,\C(:RR9O.1"=C7[\
M:'BCD[BG)B[H29!.X.:G<@# D/_[WQX]_8'*=(A*>%_M]/&0?=^)(Z H7,;C
M2GM.4_:<K>.\E6-IWI1H_@CMEFHO5S44?6>@%+^MD'JRCG#PDKCOD=)7@&^[
M5IXOW#EPLW4"3?O8+KH^$!/?TW,X'EKANW8.1];Q5Y,WQ?HPS4R)D2G5E3$X
M7@>N.1DGK K,)6'?'-O9-&A0X5+4&K4&W^$#9@6VC6R*ILHVGO'?T;@;=8'G
M<^>(M!];>*PG\0">^+N_@,,_'J[?.X&C[&4Y&\_Y!+W2Y(O&FGGP!U%$XI8'
MKP<I92AYG*67MB\WJ:CP6"/"*N[VKG'02;@5'*!ZTRL [H_]G3CVXZ%#?GIT
M++PZ#Q^-]M#7LD=O]Z3#!,DY+]V(NFU5$H9"(QHA0C+<)X_W= ^/ATWT+F1A
MSD_?C\BKNT&MXK._1N9E/*RA=\)'"CM<C6%+]S9?\3U7'G[UGBNM8>Q/UY7]
M% #C(5F](P)@G4@[O%>8T3EGJW\,DN!&;(</OCL]2"8')Y.#TPEVME!LH'NZ
MT<?#Z?GPZ-GX&>3.G?]J"8+&L,<M+Y#VU:FWI:.L[049>&?<=9"T=R2*W 7%
M\_O/Q_._R/D8#S7HW5 $%(<[76/7E905PGO\X1A.R=CIML$I',,T78O=X]E?
MP D<#[GJ'3GZ9?KQ;K;=>]9NN[>?&WH\]*=W@JWFO)E6Z3Q-RLT8MO,@-\=&
M)548 _OWOSU^]L-G;>'C1X]Z]_ M[=B#XTED_\>D'>5:%@H#.%5A;0P7')DV
M%=REHI;>:4V]R1D@0G495"SY^,%_V[->%W6219<%TI%$Z^**.35]*FXF47RY
M0N7?#FP&+2SV+&9P!8>+I#DZI\*6\-&&HS"4"@!9A#<TBX5:1GE*HDE4B%+A
MHLA@4U92!J(NH"0=WP2$6[;!?H2$Z:^"EYH@)$;2>02=*:YR3MCAZ,HBRXBP
M@8A.,^ZPGMN_8L;S)+4E,<&IU@6T/),\^^[$I#Q_^G<'E/^#&9VFW#*/8VS%
M8L)M]V!R]F++GH1;%DM[<YB!BW3-4R#<,TE)O#D+F$,8M&S7203>%?-T%_ E
M[!I3P@:5>]#O%TT^DX:#F*V]3#+>"#R5D505P6LD2U)ZK5NX\Y *--&OJA=W
M= C"+U%!<O$4;)#63:OA@55J9/;)"1_$H0VU<P_Q!'9VT7[J[.F8J)OO@A$*
MNP=.4E./J$G?#0S1QP=F7S?R>"B9']^!3A6PC\D3&44]^0TV\/'.W2OT#[B!
M6_OY%G3XT][W?GB$VOOKS'S?"+:VM[?67O0RJ0V;3B\;ONZ>J>,SF3INLB<#
MB?KPR:T)U \V%PV6G',!,&XO%GFX48ZH/Y+YM$XE3<?-L'W(@_NR.P>%336Z
M*"]L1V:L8)D:%Q%$PXMV9NS3V>1BP,P@T#]'8&,E]F1W2+QWQRE^!<AXJ^9#
M/-*YN0"7$A;V=J>&O +20&I/\RZD#ACL6,N^Y9[P35W5L,$)_VKI$U!]5?07
M>,+S5- -_E3(+07/2H!=K$K9.)0$/^$SE1Z][6BTWJ,1:[W3.=;L5/4N/;?-
M0GYX#7E^J^'9T1C(KCG5AQYFPD260M,"1A\X_ 4S:0@F3CARBHIAK /.BP/&
M*J01G+/WB)@Z?C(]?-C%3;'*^#3C2G@$31VDNN&-;78SXZA9F[@E9"Z<Q%%*
MW:$0/46(?(Z=)1@:#+KIM-XW#@)G%Q2GJ/#/Y*.I&%/%EF\/:7(?A6),G=L4
MH;+M+W04_8L%*Q>[+9*9Q/<2S4;#0^656"0I\<]QBZZ--+;JW%B)Q32_A$M)
MJSLR5Z?.N_3FTE#+M\"E7V, *,@)_K&LR=B/Y7C\5MMB\=P7>G1/5,! KPBZ
ML^0J[F4:=<@H"CGBK]:9R=%JD^:#6%L"'AZ.A -NA:7U_K0N,=1.,6;6HK9?
MH> $06\N3(F2@ -UZN&JG2&,JZ"41820$L<;K-$L%1N+!RE=(*6F?"PW:SJ3
M^%^: *OS"VVJXGD,&97D=IW[Y8T5!OT5.7+C&7)!T:$AXL7VX9>B5"9G0O D
M+FFE&,]7"<P"3EII[!V3#!D@:T;<P,SEQ@N66%[+CONR,PT#AHSB;';E/_2#
M2U-Q@L#M'KEW<&LID8WYG5!@DH2/I9YI3IX"?#Q+RUFS0OL*2WU"=Z$R=9UQ
MNL%\,N4LK>05J;)IJ.ZI7?%D/Y%[]]0_83H#GT_)C$51+DQ:XS\)Z HKX^JP
M.)0!&Y7&Q/^J<$/RJO6./O9CCW<_QDYE^L?GDL%;5"-&?A3/VA^;*]_8/$I6
M18-A>MBJ)"8&M9@"+,N1AO>F.S1@V<)YA_W+N2/1E\29)GBS=AU9T=6V;LI@
MSAP'(6U?%PICA62=4#R JMP<K_#W@)LXF'2L3!:$,<,!F:49:T X$[#S\2O,
MSZ4Y]B<H46W2M_BJLYJ$GV=IJ!IR (C\?Y56>'0ZG3_XUF"N-JX9@LO9<=0%
M3V%!FZ8'91.WWRC]I"8E9A1W;+<;"Z"$VXP(=)Q&H1';H@V*-!>W*5E2>J9C
M-O$Z(RH=KX<-4U)? T=71UO(S:@X7DKOR(AAP,D,#TF)O]8"QXN!9)IFG*.-
M'8\=/@?^7Y:LF1,OY 7(K1Q4Q8PP)'.9<BVBVYM\U42 [WX@^*<_D?!0] I!
M-)*@)#5G][[7)'0D<*. (6OJ/O++BGY)MB0<3S ]UQA+B3H<3DB*GZ P?ZE>
MOHQ\11LEN(I<M<[@H;I9]ITT)M+%MZW3\ T//L'^7X&!JFYDWYIO16(PO$#,
MV!Y&<MP,8&L;K!5(N%L&*FF7P&0RQ,$=L9]FX7CZ\SEO#7PELW9FH?AB<& O
MTFDJ!GYH$-ILL?JT7WJ((:'P#\;Z9844I(#CGL A V>DJ"4:LP&QNHH*W1%%
M5S"'C530$,I0$)-2AFU$A3E=+DZ03L6,CC*(*4D'6U)LN&5:5W2$4:K3"4OE
M=<1(%:A%"\& OV+7BB_&!X'2Q6[AX8/@M-W@*6N7X.9_54$OJ;0^BDZYZ.C"
MOI9@6>39^)>H.Y!QQ<?>5AJLJH@Z*_I5EW5;2T^R]8*&(=\27GM94""L.\'N
MO='.#Z9ID<[PY5H+1QO(>@KTYB@]<Q@T:))%UZON S"Q-2QF,N@ST'-+0?F@
MNK"6A'5(:V)D5]-/;T:;F2^PF\3A<OSC,6B=YC8"Z.V)JG!O/N?^)#PHO#/Y
M3H9/%\H[4M8M9\.ML'?.7$[LB0N JV@&K-:%:7M%=@@5;3$_K2[4?LU5H6B'
M=)(@<-A&X9V\B^/BHR+SY6YLG\F-Z="1C1(&3=VY=BZ&LYGAM^0<H;549/.C
MZ'6.601SB0*)1]7:Q+;-/1].&06Q(UAGD$Z)_8;6!Q'FZU38=_T@]E/=C*=Y
MIHU"_))3_P$?'))P )AA-GNB[>(X8KN2UQ.U2AS:)&1$^<I&^L#[*7-8;(YQ
M\#'H\;F=!6Y[7'-_!?YC7LP:KGLT.#3P $ ZRJZUMK?N.-1* $P=W92+E,S3
M:H:5_][8<?LYM@=AE<P#"4TOY.ZX@#?/J",:F+(5V^\@X5/*48@1"5=:R8*2
M$%%BY.#MX/((1$'0\)O_#+I,X <,,<1G3$%=P"FS.# 50'!5LAZ3V!([^WGV
MQM/DTYEZ;XJ^'O!M=2Y[W_>"+]GM:ZOP W)=F*G0M?<;=ZW,:_CG*D\7:>+[
MZXT *C/QISM+G7^DL@3H=#'D45BX.?CG/N:P@W;52(9<3]9Y*^&@8>F,T0V"
MPZ%$F29SS!F@ [HHDX9E(S'3+YH,>U+A,S.VWTH7W)@<16>X/?IFW+]M:K^5
M&-N%R9!/KUS1,+S5RK:^=-;!"XD %C_,BJI"85B!1,*Y([N.[;]/2&1OM,\/
MIEE1YF;C,-$+8ZI)8-"E*R3]F[,<)2^%H-ED0M-6[WVA;N@U8F9.[EGIAYM(
M=7S5I+50'\V,X?"JC?\./T;&R)U_!'%]W1^E^6617?*+E":I6 '=8(_U[*\P
MD1/N*M_4DQ1 W]K1%Y@;=-'$=,<\MXER7(L#"CI=HEY$ CL*OM*S[Z%-GP=M
MNHG&O27]*@AN.NN[=PYN"UC;:I&X\#)NP=^:^9(V2II;*H^+;8?4[N/!!\7>
MC-4Q,1)@K<R9N*WH>Z);>)5;D46Q_J2JFI4-/2Z,IQK9/CXT?3'$J)^+P$O*
M>J<S%[>@A':M'B3EWO+\_E&3!2O%']S6A,8C/^/3.2N0L"YK&0ONH,XN"A@%
MX\I<0$$ZE.#0[)3.VM@<E'N729K17'.*H7>APSB6I,+)9O:+[5(;_'DRAV_L
M$P\P)LLY"HK*XK.5=[YH2HY[KM<FR2:AW3V\_5ST6+G-L(R55IE51\I6KJ2B
M]Z92#E0*)R#>LSU_LRQ)5Z*(+&_ZX W=(O6I_%T*WP52Z/:#"QH  \(HHX06
M0ZWOQG0JS->GZ()D' E\G:O2+LJ*>'KLZ+WP8A/- *%&?&CR\_:?^60]+I$>
MO(DX2]OWZ]TJW04_R$?+ G#$GSH#<6^TRAX,7!W7\UJR@%3GUI%ICIZ<J(CX
M!;?(8=KCZ 3B35;.U-M/#W \_>V/3XZ.Q0.L44I;2".N;WTAUB<N*PEW].'Q
M'XDE\E"0"X>C@H4G8PN522NR$7>"%YU^#<+;:6,I9 EV$6(=!T:#)S$\Z%0B
MBFH].J6T;-S0AT45O&,;^&L?:A(>CQB=^2/M !=/YD3D.0,[6F EGR+^R86K
M;I/^])M_?EX_G;%+K-&#24GJ#$J3MVO1;4-\,O!5F_VY^PGQ0<.5;TGOT4>'
MSZE9O9=6%M:QO75>U<Z[.)2E:,/]U'OCPSZV0O:MN(4+1U6AU%D4659<H7;T
M0?+*0PZ[.;LJ>HQ$IZC-CD_",IF\4%P"E UH5D0 >3J)CF.8$?R_(?#@&LS.
MZ.#YY)I00[#1XL&2GIARYDS)31: <ZHPY@BV?$.;F=/)A!_C$'[+#U)U$9SG
M@P.CIM4UXK'VK=S,VQ/)<EERQE@G4+8OU %33/J9(]C*\PEK_E%'GL-%8#7'
MRFP,\6>%D^W+1._:RSNWI$&PN3U6PU-QP\W"?C[C*\49DCY*_%11!P.[20&?
M"/E'^,[D4[J"[=5Y(34KK2TJ6(0W17YHN?T\AEYZV"11!?_!(P8V,DS$QB2E
M#OFOR 6N"N]>G<J1XNAK72RYYPS9PT1ED%07%+WFT)<UC?M'$>+3L.D:.F&$
M_22^33M,N@6-3<7,[37L+DKVJ(QF%TE:>K82T<]5D%B"<SDO2' @"@+>\+^\
MI,.%91J5)&M,=&!QS YH3!];!)$W^Z,I:6(!AK/:I\J$!8['_4K_ N4:!GIR
M, 4RF G"_2 "4!K\3(ZBMEO4 W=Q7@]#Y!C78:EO\0):1KMA?6AAEB4-92%P
MC^%02&[!K.2'L'=G#>U7FLU5D@?3UPXETCL-_&Y><(2/,@.4HJT=];!-@M-6
M950NN4S*7(FM)&7<!Y)TE 5N>.N:@<\^\\ML,:$"4R?61^(CUMA/B>/(JWRA
MCGUC-WU&B._[$%@RC-23FBR")*<^.FFW_DYY'AH-? H[TO79#W]BT]&3AT<G
M3V]MF=/Q+#/M]?/^95):RR?FG-[!2#W!UB2GL4,WHT&9&]X1G2?A-C!4;-#_
MO1J)%\U'?^;^>'+TX-'M[8^Q;9 //5D1MR/22E>D<)D*U:G8&AQ7=E.:NJ'R
M"1\ZHR@PJ5@0"0W7)7&F;>/ ^ZI#D*HKZ=9..^R53Q'8;(BI'&*)R NLFS(H
MHJ8&GXQIZGC7SO8G DQ.,L4X@[]]MQ/XY?J;G54LZW G7MT#!UZ"4)1X/!TL
MK&N(MH*6?^:9>G;T[/@6S]38#M5IOAGTP3$+(["1I%W$A+N+D"X@4A<-X\3)
M;B-R-*YH0=XSO*S(YE+^(I4=R2?NXY540?5+Z O1X4(:#33[UF5JB07]"0,S
MN"G!?*P"=#@=9MK\[#O9U'+52L3.T2B=)ES7^!D6@SN_[<T;_8)Y5.W4)='Y
MZ?OX>@]IQ6_X95G8E48D@B\F_%Q%*+X'."(I#>$+:\58R"$9)[NPJ>(F@& /
M3$!3L6QFP4T_Q9Y!C9[4/UE"W*95-I[V&SL%!(>&-CUXXOJB+)HEPYP(F[$6
MP$HL@*_*DM7AQPOL>ML-QNGR-A6I0+ ">)2PERIB^I\:\.F,@WIVRVO0Z;_'
M4'U!#-7 ,;JE$\/ $!:S*U,NL9H&P9\%T3UP8& &MEN5AGRY%G1@F#I6,%5.
M1V HF,27H_3P\ Y?(!:SX W$+@S(E *P<!ICVQ':\WK!\15P#+B:/F3;LB9"
M/*:O'K)85EO#8YN=HFG@#&)7Z$_FDL2SZI+:=&]:PLI=ZPT;T=3%VF >HOQH
M:@$8@4ET*=%DNI2Q+@%!;+OH;3_WUPB+%/S^B*-K5\XHTHY6S@B!G5]2BZ)!
M;XF763CBIN]GP6Z?!5M^Y"M;[3>\\Y A?-19K#9/[AAX1B='T8!,4C969^"A
M0]/G 7RN2Z,S5)Z@=SJ)DFEQ>4]?>#V.ONYZB5[HJ;3X3$.YD/2-I_8*.+'D
M'*8NITCU:_97EN-6E?=9FEO8)J[QU<F)EU5SL]WC]#G.&^X\R]<RG #]*UA*
M(P1;OG)9ESX81EY$.3P\T>*H7XTY,,51] I#19*WM%L+04Y&<K6XEV>(\>C$
M!CTB@P[-6@&7N*>Z(-,QR8?WP';S^)/^I#W::L;1OO9<$(A7R0ZJU[5ON=@R
M1?N OWPR8OPE@]&H8.Z+3O58J(Y=U%4YIPIN 1O[QG"\.[#CGHYXQXD^VD\%
M-#KL[%;L-;.[9+?:HTI*A"75L N<*0P,S@5KE9F&-ZL*=[\A=*=*/P9=?6L$
M2%D+[JE0ODB OI.X9'I4QP97>XN46=TJS\2S$ X?"VGS[$F=-SF% 6\'K_FW
M>E/D;+6F#K_LS3X*PFU_FB+@H&HA5: F<YF&-C(3T?:;FD>#)FC'OJ&60#TR
MF.+2F"P9#DK#@F#5B2.GJ"Q"=>#IW8<+(*+U;'HTO:VQ7\"%:%TQR\;0[77)
MUMP@FJSS8(Q968J@+?=QZT5KC TTIL;D4MWL8VNZO5=[=C#>@8V<<NGY;I>M
MS:BLZ3AL]70K41\X,N#!8E\UY<ZT\6GX=+MEKKE?E)EH:8GQI#LS$ ,_&%3)
MD8V/@L44JE90@V**94I2%^N*P*?88BVAPTK?;%N.X1-D%X0#DS6,+W@,U3).
MN4J*JI%(JB25S;7VOS*G,H>(5^D!C*?JDUO\ [^07&O)Y&M.U.!QGI7IE/?+
M@"\* UXXE@GA X QWW3];&LMRZ56V[Y=?F%#GNDMDT*,OAJF8N<C=PLT2VSE
MLU]4](C"I_NIXTSJ[H56N,5[GNI;33!L=5@L+.#6F\4>1<*:F+3*F5D<=NCV
MTE X=*);<8C?8,3&N$/!XUD,1Z*S9H[[;8"MCMI!AY"5+@@GS );(?D*\>0_
M<]+HWP&LG!]QX$KZYZK6YJ7TQZ':QLE]L/>^5\T?BX.GU[0J0LO6<W>!11NV
MHI!]NK2UMTJ3QLA!4DF<NS1H1ACJ0JNJ?8[] 6GWOZ6.-UE22612PN6A<6H9
M@CRM'(7] E&BCK'3XV#:JU-ZO.V4*B&0=X_D?BKQT54=;#M<_Q90,-JR9ZX+
MT^UJ\]!+1=@RDRH*/,H2CV<FLKZ&>%C,MR,T.+312OIO%2GUT&7?=7R.U(;*
M2!C=4NFEQ3PFY02'62JGP!ZFRBRNMG%E<L./.!A]1:0(+N9"'X/]<*^M[[7U
M']/6*FC&VUH9FG*0%ZBYZ21+25Q;0WV>R@\@YAC&ZE-^7U^_WQ^INWFDA.5L
M!$<J[Q(6N;(B5K08O&^KO]B&UCIA>=4Y1FBU>(-SK,<%RPZFDQZ6^RV$1V'7
MDDZK$AT<O9T^'['E7;<C#?U@:7VY,S9I@V[\^(L>CJ;PW??3X!X;+'?;6?Y9
M>E8MO)^%:_NJ*(E&XQT7$=VN_?VF&"SI\0VD+,!8 ^R(J%I7"^4^=H\!>ULB
M!:>,*ZT6?1XGQ8T9Q&?3/1T<LVUC<%\-\06K(<;%**MMJ(O$4VN$VT#HBCVG
M"17 FCGFTV/.H<81-A+))"N9'_YR='[$O: $.>7DM-3SZ=:GTC0 $>_>,25=
M2'1V/3ZII9!TE6W33=#\[:I$#9:[IBAED:<SQ0?K#E#K75-.NY5S0HDY%2J-
M/!;:W,7K\$<I/UU5,7:/&Y-OMHZ@.^>VI1PR+/G"X]F%0:HNHCW!N;I,,B%R
M'9 ;Q 0RMZ&O;IA(Q\3"7+>?Q@/5+D$+'2J*G#?XV'9F5D/2-P0)Y39(\%%5
M.ST-=K@IJXMTS5JZ:K!!"?4DV0G]A!G)4M/0#[DH4*^TCT]7K<6<]+*)#.%+
MRP[O+27Y,C/GWDU!Z\ -=^" %U0T0HD-/N2F=E-J4;-N B75R_.GZUT)4)OF
M_60\[>'Z#(S,A8W4*-8;KQA</6@._A@?.=AS?6K!\9.K1E?VH :#Q3/,[X[\
M+L3T8LFHI6\GZ^!.VSP\N6NTX>I!R](S\70[=@@7V2FV+6PW:P1AP=1#1(PC
MU2_"CR.\,.(;NN,?LC2%<X$O]GP2<2MEF#QLEP2'8@H38V]NRY"'-I7L.2;L
M"TY'-"V+CZ8\!.>2>WG)WL'C3G'?S@92I[%;3)%6REK JIXU'8ZTQ'98,]D<
MV&9QY@A\$O9G>1Q<02NTH3?:<V3:AZ78H9AD+)'\A)I7KVO&P>Q0,GUB= =K
M4;JP*PU>.[(D;5JC>2>AQGX)R0&+JN?)TFBRI2TYR&%EIW],[$PG>:R_&&.?
M\[@?HB&887AU47LF#S5<>PPV#.M>-MQB6@ZY$84<YW99+.FHNOFU"D+P /C=
M*"]TY=F1_/!I4[>X( 9N.F :,*3G4O )6_7MS>08=Y=;E%S3"9MOH'3=H5-"
MCI#]]/=&5R:WS>$#L> IR$DBO4PK0>'@,L-?UMG8&F < 314'T&J'* RT=TX
M/ 611#-WT2E)19,8YR)=P<$4V(^O96#-:%NK7!BV,PTQOZ'>FP?S.6_/YZ:E
M^&R1X#;N0F%,[P=5GFYY(BIB[/ZC/CK8T>:+)!X8T!/WX!9SSH+CP:@XA!T>
MK?'ZJI#(M9^I5GR9Q<_ \@C5XH0(,XAFL#WCBX[>')J1#VHY.3"WV)EQZW%G
ME"7O&B7W&O/870Y^#U-<&6IWP/SY2TV_HL1K$'?[[#VQ;:=C<(.NS^>N#HA3
M#G.'_I-,0E]]D++L&4]H#<S(-Z$6Z\CWC A.HW,P<"?U;J3]5 6CJS/;I@KP
MB&2IW^\_)5=5')EZ=MOAONV&:Z?O9YC?FAIQFB3[I<PZ#V#U*.C>WM2N'<M5
MT8 U=9D6F0W>GR?E-(&O#M]^RLP&FZ[B]CYY\."DU1+C\]LBTV-\4V.&0DB3
M5QJE:JDRWD;+^WG E^,YX#MC^V^*Z+U!M"C\YG:/=*MA [94JH@?EL-.E=VG
MGE/:VR:RQQE4'^X[EZ73)0\QA3QZ'!V+9]=EWB(0,-+BJE%G"'@W\R$[)J90
M1UX,W8<P^65I*=[:SCOW3TSG-LEF[0.'N4NH$M;ZAZ1THXRRD&T_FTRF%SP6
M#B05<V?;^[;D@\,DRD"2?RSFVJ4/$F<I[1ZR\15O22,NOR. XE#ZE"09.D2/
MR;Q8U]Z:XC0E.I1]8BKOQG'<VK<BH)4((M CTJ@+?\3\S'E1MD0]*Q#J+8VQ
M( P@3YO-(>X[6 J9 'K?*S1V[0RX5A*.M1%^A1-]G5^I:+;K<+4/M:7/1EQ;
M.MCR8Q^UU+:)N*]#_<Q@ S(E?IDB5+S3EZI ?78[%:@>KC(P)7A7CC-@CUAL
M]8:O73G7W#K>&4P$T=C2(_"2WJI//%)K0^<JA,OLX_&]6V57YW69?AQ!G<^?
M4W15\=O=A9*KL2S$30JN2!1^G6JKG7&%)!#QN#U8;I'$/.CGC)JHH$(/&YSN
M,QCI]<%T9V8P%;4UJ[H015!BJKK0)ORPW+L'&GTQH-%H],%]!<\?5 VG[;/=
M9HGSQ]B:8QT<5;<LA](%JCUJE<!/+/RXFEV8>2._,VX>=,!# !^]Y[LSY)8!
M% YW6TU29]SW14I?3.7""MU7*-V74^Q+A=(^E5.XS@9WM98"7^"^D&(L=L]G
M%%+<<LJ%8BEC!89++Q/J)\BHE1!#9R-!P?@L+B\$X-C#4D57"#T5(-"7PC]:
MST_'"MA3'#+)6)1YTV!R'0BE=@ZO"Z D 5$.FI#1 ;RBC^)-A 9-)47P!OD-
M[D#C"'&9WH'_(J#,?N0EM=1T:4!I(&E!C;54Y^RG!+Q3T,)1%(O]T@>R5FVB
MPJU%V/XNH'< 8KVM\:\]4(,-I59-5J=PEOQ10 %0522*J$/%MFC7<!NI]NNR
M=+38WU"P"&'=5RU2^M [Z<R5Q\-P=3QIOKM@IS,[#G:C^W/4S/4FW6<'?<Q[
M./-=Q["=ZXBL-1PPOCS,?'J[\BE,@*D(,2DX[G=#15-]O@\G^FRF(L3(H .F
M4/Z)K9UJM1?$DR+$GMCMQN0&J\L2-OEP]F*>0[75!\XD6D8]5Y4,H[AF<Q;N
M>JTQ*L,+URY2.Y"^[$%4WCM:/@LDC:P8]J<P,G8TSC1U[<0'!Q$S2/E:%1^J
MPT@P3".93D\X:H.'$A&\R9VW#[=JM; /DA#R]L/CVI&<V/'H^WC4?3SJ#_+;
M+5R3IV*=YJ'\"$!@VAF3NL.DF:=U44HBUWE^/@"/_74IJ)7,L1FJL2S">!$)
MT_\T".:H'$3/MQ*C*+>[CVK<PL@^[&:!? )X]BZ+="_07=^-&-WUWF">GK2=
M%%# Q'<^_"5/]Q/O=8_J^FQ4ET/=WF +W13O=?U;;^'VOC8B[+O;0(3MY:&Z
M6R@LW$,O3"G%G5(&\KPH/D9G>5UNV!@[ SN\H%J4\Q3&G)31:5EB<F1$<9O!
M(]G.$?$QF24-JFYAG)OY&4 4.F[QTN_@//$<MT']-H4LI(<<LX:X.Y,%?E!-
M.C8X_^CZ#\'UL(U*I[ NAP;7!4_QJGW0V]8-=XRTYGPL/ O]%4NNGJDC89Q8
MH5%TFT_"N SO#VF.0'DGSY70$R=#D\NZ-Z5!1)-[]:"<G$?"/EPGT6=#1WW+
M@J> 0S,943G-&FDOUJK&MZ^!+F'BWB-Q;4PJ.#'5(IF!0:CY%&P",XASQ[X6
MM1UTYDW&2<P#>'<P+WGAIR [/TXZ2;K>=:#"?-89' 7S^N)U*Y4H:V:[7_@)
M4*\F2HCSM2*9!Q1:SXMVIXI@)/@ZP=NJ5H82M<-U1GX<SN&D/=&UV*=Z%%ES
M8!BW*X/T5MFFY%RF8%@I==,H2VMXM,,NA"5CB8F]?]/,+(T00P2-4"JG5KNR
M:1L3BW\(WN"RP)W4=Y>CZ$/0XH*I>%P(H+ND)3DV"X,E)%*YW1:#KC=FS_%5
M6T<3_J@&&753YITBIMAQ1LC$]8M4?4OZ0=6:S_"T8,2V+N3A-MUNW&P*Z614
M@'.WE.B-5###8UM^X7X:)'<1!LAVQZF&0L!2_92L65.\5^?]]N.RZH!)]K<M
MT&_N)F3TJE\,<X>?W&-_]Y9DL&W=NNW <6H,6&DJGR9'>!8214B/HQMZLLQ(
M-01M(E/8E)<J5ARH4\LPW:.&CQ!J]67Q8$,ID18:++.BQ3).>U[/P+@0Y7'C
MV1HIG"R\]2"HC&M;]E,]WB6TV$N%L^K=@N>46+-GO7]#WJK"_*PM]/3D&EOH
MY.'1R=-;VT7I>'81'26%9W$U!"+/=ILK@KD8\!_BG2[7UM:@SDV 6^>%,]#A
MY\P(R>R=G3$IMR F" S7[-W@R>PG>]?5A["P_+^IT!<B64V/\O/6!P :9O4C
M7 DZG?@?$Z3*?>)]!N^Q-+96L!V! K'?=;DM@E+[[100BC@@E L%RT1?0?<?
M=@0]SI-J+I"5@=!WSCDDF=)>"<^IT-U)"NH7'91%0_T>Y\55[K!0!D=3,W$V
M#6UR! J0ACQ7H"8:&JIOCPET+(6]%FY2PU"F39U(AU7BEJ5E:3!@Z1 ZP_$M
M, [X%OU>KX!W(EP<B97M0BEL@R8Y*M4>A*?.G_NP"9O]?JH<+Z@*H;5M%57M
M: ,YZJ.TTG& ]@NK: ><4Q>'"(>A%H\#;/*7(E2N,&,Z3X7EQU(Q]U=3#<>A
M9*]R)F*#M+-LP@YE/0@8$4P'$1RE%?47D==&MF !3RAL! _"ERI)D2DQ=WN2
MM,X/<$ P'\-^UA]7<4^.'CRZ/14W.AW'G71O4+:]+>S7_%&-J=%(_9;7GZA)
MAH&>!VUJ[93A5B&U,U,/*M"V*[;F?."N=[M'[=RC=OYXGZMK5G)170F>&*3L
M0EBP*&:.Z=(?%)3'OX:([N7<X8:FKO'#U/B*\+TW_"YNOI"9S\W"TH\J9ZUS
M(H,1ARR>=N0,;K;5OJC@.<4^@?_;%!+4NX:PDOP0/=&U+JF8QJM_0OKG(NZS
M1^P-^\%_O9ATN]#^C5TJ("S1Z1>]%*GI2N M2]/.CS@U<0VM@-];W.OB&B)>
M3018"@1RY8ROLX%HX#UFDIW**CIPJLC.;COKNO &6%0,F9C@"7#1SMVU7(?4
M:&#+#BQ$*\OU.=9MW^J @?>5+%Y^C;MB]^YE;/!.U5']9)96(+3WT@@@<R'$
M1O6)[,8QA9,]Y ;SH0&[\Y'K.\KHI1F,#L<ZI3R]R/6%="/C?V=9<669@"T^
MQ)GN(B?Q%S[U;L4M%BA6&M 1J^/@$P>8V-;GKE=#:4E*G58^Z]P\?C2F[-.'
M]Z=OSE^=O8_>OHH^_.OU>?3B[/V'UZ]>OSC]<!:=OGD)'YY%Y_\Z?7]V'KT_
M>P?_.7OSX>QE]*^S]V?/_V_T&C\]__#^]0O\\-TO[\]_.7WS(?KPEG[WX>S]
MS^=\9[@97O7+^[,X>OWFQ5%T\N#D873^X>V+_XU_PTU?__LL>O?3Z1MZZJF^
M+5]U^NOI>_CBQ_=G9S_#Y7'T_.S#KV=G;]HWQI^_.X67>/'Z'8P%:55>O'WW
M?W$8Y[^\^)=Z1GA#?)>W;Z)7KW_"L=*0W[V'.\)=?HK._M^S%[_0$-^^@LDY
MH[<*'[P'@._C!R-&?+^E<TZ'[_ YL?7N<V;K'M[]>7B.5OX8<5 @\$NOI\)"
MVM+BF;S":B,QK7ZQ?1= DRS+9,767=PVX7I3L;4M317OQ967.--5FDQR@IW,
M=M[<:/,GT:(AJV].ZLN%?^0*V*H% Z?FG*#67E^+H[.':!,,\@P#4,)YH CP
M]%-B!V=ASZ#JMBX3W"+UL*8F>@7_=R"'[V .8F,,'.\_3L!Z#YW96^C,UHVS
M@V^7-O-]D<2>%TF\*?+#,T+:@(1Z29CZPLJTHZ]EZ0Q8WCW2DPLA1+ C^COA
M<MN>=Z!VM!X%R_V(.!<_\ O!=;&>O&DELXS) <"VCBVH<M[YI##PQ&$)BDAQ
M=,9EA'H#DLEVBHR $'8G05 7@,8+XHK1AV):G<^=DJXW:Z/U.0B8&J%?B6N$
MD%8D86 WMH#Q'DR.Q:X.*_?X8#JAZN[^XI@>8@%<+-O,JC/)29XW:+J!G^1"
MN6<$XT![Q,Z?]^3#9Q)F0#7*"MSUS_>1KY51O441.*)LZLG1TX?;9>!I P8+
M?#KC4W#+H.NS76(CL<.E<-#4.)F#":,M@)@K0A+]U_'3QS&\0S<! CM5*&7Z
M9 ,'MF,Q@UNQWAB)9E9H95ITGL7()MS]3UX@K$B0HJ+GD^&Q/G[P>6,%KX#$
M+Q_>:&4,A>.NT2H'CCF"=WIC[T-AZ2%XJ9)=^WG*QW/,OSOZ[LGV4VXYF/N.
MQH]>:_>>O#&(A!0T:9ID6\JSE>U!#9.P/% L\8)ZKQ4I?;]-N!!K,MGM)=(-
M/YS@44!*+E1V;(C(F<*6A_ +SNHY;JW>>WMH.V<Y8?"HYM,<#W"OI(B]=[%(
MRTH:8:M'4M$8CM6EV[8_F7HVNG0@^O,'QQ/NJ=F65OW3LS))U2#RCQWXKNET
MIN3-M=9(ID#X?7HVG5Z2L;SF/@1QCT<<Q'UG2LK3($THJBF35YRSN8_EWL=R
M;\Z9YC 1%&F$4^Q;ZN4;B<8$[6]]-3$(@^,'+=>FP(MA!R6V6E>RZBA/MN_<
M_@%3KZ-^AXP'BL6Q8%=Q!!9Q'H=3BF!M?UBK1[ JDH;UW<L3=)="3B\#9([?
M$J3QW_N4\@Y1>+O'[U?.?R]QMY&]I>#X>N#OI._#8"2BC\U0(( 8XC#Y$C,-
M@@8:NC,&482/8\>L!;P> AS2OX#C!_=-&)ESE;*[TU02T0J")/IW/Q9)!@/@
M&WZ$ X&C@8/[][\]>OH#MKLTER:3$?;]ML+OF-^LB@ZP<()F=;W.-MU!OH)_
MP$3'KOC78B$J7R"&43XOH3KKU7GO'3/E[[=[<3$LYIAG,;.C5K?#6(]&H\P)
M^/0P]U5D\F9%M9LN@)Z";SU'; 98]-W>Y-+<&-G%/4@*?HE<Y7#=?@J\.U7W
MWW?";M]Z^(+GWJ9^6#F+IP+;.4ES%Q!B2I09BP(*CZS5C<+(#(@ +SLD^;HJ
M2A.=+A9IAB>ABBGZ+5V2X:*UE &#]]5PS+F' MGAI22B33)*-V:,HVE3APA!
MBC+3/%C61!V])7:=W&"XJ<SA0QH,_BV\T =3)&*G%Y#>R<@,+7UIB$\'Y@QF
M!<D.THS*L]R=?+.X77>1,938 ;XQ=@CVSV597-47]N++"7Y05?;K./PSO-I=
MO"Z+14K5[\'?X<4R#%D+YI7$J[8/_Q*'S[0JUOT$'>"X8WA)<#'T2FC.%/YM
M''TX?Q_;&Q78T1X]9T8Z)Q7H!GU7&BA_"EIKEJS3&GF^4TL>X#Y!X"O:T2C_
MDRP8-0R;H,<+V _7'[F?'??C&+QM8_3?%$MT]_;O),-R*_]IXK=+[R3'W,P>
M7@HK\E6K7[QLA0P)O]/?<L-/=KW]D8*!LJ*H[#7PWK"P\P8S(&BMT\'SWZ82
MA;8=(G?,!V\A/W_,U%<C\7AGC2?^(? 4\PEU-C93+9>PCNX[V+1^[&:!946@
M)S?V>_R:PK<8TG*/Q9@4Z#@XLZ5GQE(3@YO[JB@_\L+1*K0?3!M9WQ"4 4)/
M9C:3-)^;N;H8KL;]EA,!%T:#RB)S+X$KBRL'DPBO2#>PW\%7M!7=WSCCG;GR
MWZ8R;;,L16$,7R-2I]!7X%9&$ZA.>58XB;@R&+Q2SX&I,S9DU+T-?(MN9K9I
MA:&P=[MLF*A$Z=GX.:-YE5]E29.S.82_@/E'VHC4Z&O3H;5;$UC'KPGL*S0K
MB7H[& P,!']_#0DC<4_BJ)A'%VDI$HU^'K=NZ]1;,@.!P< 7ZOI>E,LDET.F
M2M/ 3%@73- !CFZ56"8XV-/PI^.GL'>=-A4RV55>S_%!L8D-JPMA HK2#A)^
M-<>YF.@))#(X"PKV<TGFK?MK)N: IO "HP_3S1C>U(K;7[J]K0"/ >N(/M'F
MWJ6:C_KM$]<=V792=IN @$EBK^27:5F0Z4'-&XI9RFT;K$FQQ'AU3G<>=P/;
ML_,?Q]!&S_HF:C_$/9QNL?-AU&*L3;'&(G\G+V(Y2_!?D\R)7CJVQ2;P6]*V
MK'7I4WHB'<-Q+]7+L]=C6"INWZ%MYAZ7VQTGL=L;,=L1QR5@/5B2.3I]&"5
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MK;=/S_>\X.*9392LJ%*.N.[06Z_6]#<*IX);"%*XPH7 /3973%4;2)7P(8:
M":P!@PZMS7'EA:SA<YMK$;O "!M.=N_(<MBB1EJ3BCE(W;(X3+#6$&&EA:5*
M["5(M$ 7_P&H'$.AGG+3+JC@H)NG!/2U%:V8C]L<!SN(K)-=3Z. DF<BM,J:
MO'57U*9J8DH&PL!J)QD%T0J)AE:;JC8KQ"]P/I:@%OX.+3I<"5=FJ<W)XHW,
M?'*_E7=MY7'.S:(I43"-X)3[FJP;'?.<JPWU*5<55*N$ +\(Y2(H[YQJ</$O
MY@$E>Y<+9N7PM#!<^)&(!BJZ4K MS3%,PKTNJ &*9>?P03,Z^-@2FJWDJ:4A
MQ;"T/?Q2QE&IZC\>([)":4A<[VB..I4CM6YF0,@C-Z_M@K/"$TUPX4>AS?[C
MAUCPL4U6[B?AP5TJ8_)6E:/!<>"U6R;"":M$07W$+9^QCQ&%@?9RPK8QQ%PE
M7+2Z"3J?NR)XFJ*8=WYD(;)XX]CQ%P_9=#.4+%E@VL4[#KPDOY**&G[@)YWQ
MPH$ANCPFVR'U79=%(A_<!25ZJW7\H:*@Q;?+>Q.%85<WZS42OYCZ:#=;O 5U
M<1=VU+U9-F:S;)OBCU6B3V&I7;"/\]^^<C3LYDR="[598JGN+7&F8A3LHYAH
M Y/PFO.Z3#^VKB#LTX$E@ ]Q67C<1-)36JE3)F@13XPD6&<)!A_E:"?4)RR\
M[D"^R8HK>/4N*X8>H&L/0IAN]JPFOFI-.%-+;L2G2<384;-$_<@RS[CU320=
MBK"2 "0 ]HBDKCR455NDV'$JI<9V(-<$94#A"2SYM20/!T'U!%,0^))6Q2A@
M<1AX;]LOR=/G.Y@%][CT#/S=!:B1%,5G];@7F2<[( -ASC0G6U^PS5/1Z]>+
MX_SG>\J8C6Z[R7M!U?9HQ('G'\$E*O?5([E;@=Y1>2%GB4.3A;0XBN>:2-%F
MG*/JJP'B0^^N]^1+-J[70F3QE1;YZ]V:5OVPB U^7")^2A<OQA;CS@9XY%A)
MCY-<@^CD,;VU@,- '@7R;N.$F#!KH1'0W"Y$$2IMZ\-!.+L^:J&XCX9!;BAJ
MCIY)7'0'B T ,YEI>N&URR)/9Y,=34!VAU\E X"X<_<C4+5%)F1$R%GAIRG1
M+.J@TEBY1S,#LT7F#/<?BS*#[0DG=J_9.(WTB ]=Y1R1":@>)9K<-RL,<4*"
MO\$BQ"2:-^BP</NLWZDOC2XS;*FM_92<=RF6\W.:(V-;]&\I%'SODPFW*T/_
M,#=-B[VX)8@/%"X9+=Y#)M3G'UG&&:+J0*!L K-EKZ909UH2B4=./3P5Z<N<
M#I\VV1P%C0SDWD>^EB,8,@3)6@; T!:.Q$6?HY5L:5O[JO)CC,'$K83NX+GC
M^G'%'.2XG3.=FU>YH =@_1M<Y*!0FUPE]5/XK2W_**(SV\GB)3Q\5A>E%(70
MIA*J)+NQ;%D-3 :AWP=WEM3N.*AA#HN)5R,%H^V.C%K2^R*5=VT2)!K!N/OC
M!]&5,1\U9$R7EV#?=$.'CKM?";8M?(P4R-A&8RAU<#O!!:X"INU]T=#CJ%E3
M>,J21=*L4IL/\%Z)X.CQ?[N^F)Y?D)NLHRHI+XU6, O-3MHZY7T5^(\QP7"@
MR1L]-UX[A#!QL+FQAF[&<63'.3?C"6N% DI!WCPRF-G-1)CUL-\K>-IP1U+'
M(N6,[;X>I6&?<\N/$!(P]%KNO5QN MYW212O]'1H9S\MO3O%6O2&3",JPY U
MO7OD1??-]F[8:.B;?ZI@A(\^>+8YAK1C$"+PY52+BCZ<>Y8N#&+*T"TG>"V%
MX:LJ]53 84E-O(V?A@EI$"(/)@B3,09>(WH#\@J6.[EB-Q1S<*G!="G\<YV9
M^9(^JVMX:?P7N-"A''*52"5'2L$O)F9F"<2$_JQW$:8;K@OT/#O<FQ5+#JN9
M!1B&#,(VNL(=Q3#T0(U:>>@V@4B#I\MY]/$]/O]+XO,'Y,5MA51I7TK?IR2#
MQ?9U<78KEF3'NI-Z6:0<IVMRDX.ZGQDZ40EUMJUU+$6X35VK^%XJ(@[*N1X-
M'&;3."/O8F$B1+PCY.?:L6NO_6KW;22_EN#?@='J^&?#%/*<8W4T^9I**T?A
MA]X;<^(+*\9$8H5:V+;%JP^%VI2;0U(XUXR;HW%TNL^C3.;%NHOIV0[C$4)\
M]B.I7*\W*@Q76?(/>/V*8CH%>=$V*\C+"/XPZ@^;&2PZM6&4=^6Z:R3+@#LT
ME6](A:>X;*3\!9Z)'>>B\\-GRI,]]TF_4YB6 ]A1F07UQ'8PX_3 7MNH0O2*
M)^MGFJQ;3<_(2HEK3]Q.L$^Q$R_N^VSC: 6D\4'/DI) OF!F?#P*0Z\ICT 2
M$:2*KG/X# OLD8-/NM"#J!;_:B9B'+99)5:9_0TE1G1()RG-'QL3,E"_U,W,
M[4E%8D/?H<)619J4+D(Z0#%_7,(B.)2TU_W1&Y8H^/P3RIM<OT-;=&#0E%4C
M1=L+["W^\2PC\  <6J*7B6G>[7M.X37PZ&%>*\TY[%4:D4P8 U+G>IQ'Z9W#
MN7QP$S"&8[2C9G698MU\*+F3^24WL)!D&J>P[&I:5;4M?8E=40J4HL[(4*04
M-J-58#9,'JZ'I$I\?05AXF\EW3!V=+"PFN*^9>Y7,V@^M+&Z A)21@9F;&=P
M?.:^0\IP=-OU.=3]!6QZO>>X>9>.1 >7AN;*9F!FVUTH8@I^]S:_]E02](#M
M8[&-$&SK@[ZK6BD3--7J3# $_N2XL&"_PWL=;]<KTQL.PS(1,5Y:K:0 W80[
ME0 )?J*PCI]A!PF6)$E+480@.*P9M>,+&BA1!G^&31&LB!EH["14'C/A$M%)
M!$:2RY M'$&&NJ7(.+ZAC1H'DFG@#8,2L:+4[^H-CW!$7E]WB58<=XJ*+^-%
M(IUYU_;N1$N=R9R9/&KY%=LC+%%]#(9(.(F 4S\4QH#:(N]#N+3R.CJBHQJS
MOYQXI/)_&J9I$5'=TSMV)]UUK  I%9$V;7&WU1"#4#B-UVJG+<8-KX6M"/#]
MO\#7GG>PW1T78R=.AY#L=J?VQ@%M?*YGB=D:#0HI6!9:4YD93Y!?BO!'J3?G
MKOGZ^YD>F(]'@>X$@KR4-IUL<MF_HC/?6GA,E3W]?@7Y+4YVA=Y11=Z4L,U;
MIC?51)D$55]'Y5CW> X[D89Z(^[K\NBQU:I#",II4U)S ,19<[LDPD_-K4\R
M34!=Q Y5UVL,7POY-NB"[1 9KM\TH1>48=2.X*!/:F$'7%")H.RJW2Y 1754
M3C)(%J)KAM^Q=LLUIF!HQM]+*A5>7)IB!GCVZBCZ5W%EJ&YG'FSPWM[9KD,W
M8@75HA=Y+I  T=VZ'?A%P@G<C:DM+L3)UQ9&I4I6+<(3 OJG%37S%$I/ZOK)
M7@L?SXU#P"B@IRAMZKCNF5H[/\ ![6F+Z-MDM;MYQYCD4_2K/RSWR<^OY#*>
M]CM:@:V;:-B%-^TVWK:+=7BA]PJY-1FVM2W3HU])T&D:@&*1P4MV0\PTS%14
M>B/ETE4G%K&F^K%Z+QE+<MR#X"U,7KEZ1*F$$<$MM*M%.UQ/%AQ=0SWH>+0W
M'>/$^NYN";0.J9-/S,AD;5VEKF-28];YBAWA2>*PX\ZEM>_N7[WE/U@N*=<?
M.:@%\GK5^U=BSA;K-%<NQ*!GA;D+F-X*B6/1BY["@17:#&<SVX&+WM3S0./#
MN;C/EGTM2?&KMH%L@&#)!3X$?UK8"#-A1SFD_#E9M- N]1N%?LC-HCF.A/:J
M;95IH6-ZD_C4P0%2$^9%0.9L'+[2G31F'43*F-[;4&P?(TF2)299LMG2 /M
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M1#\"\I%V) !VD()#*2B>4U:MJ@!LQ%5(9RYV-1P$N]5-.C#$.P!0E X>;J"
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M4BG?M94,8<,7A%KJF@F)1"D,O".PF>H^6%T1U&;@*8C;62HB.@6^BC4N *N
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M1[KYL1VSN\^YIU_YC>>OIS0S&QFQ"8.D\@TEMN?E:P\MW?7Y_!$,$G,5WZ$
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MOQ[/&=[[W7.!2NK^/8 6Q.L>=$YTD(,6^#D;B5T<"3]4&'Z]4YO$%=L!YM&
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MR*]&-7=F61 6L" =N"Y+!>SJ4FC" 7^!O &XA'':AG\Q,4\+K4=;<@' 2R<
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MV']S^T?WT;T.O__F_U!+ 0(4 Q0    ( 'E>NE9!0CQEY"D  %4: 0 >
M          "  0    !A,C Q.&5M<&QO>65E<W1O8VMP=7)C:&%S92YH=&U0
M2P$"% ,4    " !Y7KI6Z^E:1-5Y  #1/0, &P              @ $@*@
M83(P,C-S=&]C:VEN8V5N=&EV97!L86XN:'1M4$L! A0#%     @ >5ZZ5L,O
M!/QI&P  >?\  !$              ( !+J0  &%T<F,M,C R,S U,C4N:'1M
M4$L! A0#%     @ >5ZZ5I2Y4&EG @  ;@<  !$              ( !QK\
M &%T<F,M,C R,S U,C4N>'-D4$L! A0#%     @ >5ZZ5A)334!$"@  $5T
M !4              ( !7,(  &%T<F,M,C R,S U,C5?;&%B+GAM;%!+ 0(4
M Q0    ( 'E>NE8M8P71JP8  -PP   5              "  =/,  !A=')C
G+3(P,C,P-3(U7W!R92YX;6Q02P4&      8 !@"9 0  L=,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
